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This research investigated the synthesis and optical properties of Au
nanostructures with an aim to use them as imaging agents and photothermal transducers
for the diagnosis and treatment of cancer. I have produced Au nanocages with hollow
interiors and porous walls using the galvanic replacement reaction between Ag
nanocubes and AuCl4-. I have engineered these Au nanocages to have localized surface
plasmon resonance (LSPR) peaks in the near-infrared region with strong absorption.
These optical properties allow for the imaging of biological tissues at deeper penetration
and the photoablation of cancer. By replacing AuCl4- with AuCl2-, Au nanoframes were
developed.

With a series of discrete dipole approximation calculations (DDA), I

illustrated how the edge length and ridge thickness of the nanoframe can affect the LSPR
peak. I validated the calculated predictions by experimental measurements.
I functionalized the surface of the Au nanocages with antibodies via Au-thiolate
chemistry to target cancerous cells. The photoluminescence from Au nanocages provided
a simple and convenient way to evaluate their in vitro targeting capability using two-
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photon microscopy. This mode of imaging can be used to quickly screen the interaction
between Au nanocages and cells, as well as evaluate the distribution of Au nanocages in
tissue for ex vivo and in vivo studies. I also quantified the photothermal effect of the Au
nanocages targeted to cancer cells using flow cytometry coupled with propidium iodide
staining.
In addition to Au nanocages and nanoframes, I have synthesized Au microplates
using a biological macromolecule, bovine serum albumin (BSA), as the reducing agent. I
exposed the reductive hydroxyl groups in the protein by unfolding the structure at an
elevated temperature, under an acidic condition, and in the presence of ions.
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Chapter 1

Introduction

1.1 Gold Nanostructures
The beauty of gold lies not only in its yellow metallic luster, but also in its
usefulness derived from a diversity of properties. It is the most malleable and ductile of
all metal; a single gram can be pounded into one square meter. This noble metal does not
tarnish in air or water, making it attractive for a number of applications. For instance,
gold has been hammered into thin sheets and drawn into wires for decorative ornaments
and jewelry since ancient times. It has also been used in dentistry for fillings and crowns
because of its bio-inert nature and ease to mold into different shapes.

Gold is an

excellent conductor of heat and electricity and is used in the electronic, computer and
aerospace industry. With all of these favorable properties, it is no wonder this precious
metal was used as a medium of monetary exchange.[1]
When the dimension of Au structures reaches the nanoscale, typically with at least
one dimension between 1 nm to 100 nm, they exhibit unique and fascinating properties
that are complementary or superior to their bulk counterparts.[2] For instance, gold is no
longer non-reactive when in the form of particles smaller than 8 nm in diameter; rather,
they become a highly active model catalyst which can be used in the automotive
industry.[3]

Moreover, Au nanoparticles have been used in colorful glassware for
1

thousands of years. The oldest known example is the Lycurgus cup that dates back to the
late fourth century. Silver and gold nanoparticles with diameter ~70 nm are embedded in
the glass wall of the cup, which reflects green light and transmits ruby red light. This
observation of colors is built upon the unique scattering and absorption properties of
nanoparticles which will be discussed in the next section.

1.2 Surface Plasmonic Properties of Gold Nanostructures
Gold nanostructures have gained significant attention because of their unique and
tunable localized surface plasmon resonance (LSPR) properties.[4-6] This optical
phenomenon occurs when the conduction electrons in the metal nanostructure
collectively oscillate with the electrical field of light (Figure 1.1).[7] LSPR is responsible
for the brilliant colors of metal colloids, such as those first prepared by Michael Faraday
in 1856 from the chemical reduction of gold chloride with phosphorus in water.[8] At the
resonant frequency, the incident photons can either be scattered in all directions or
absorbed and subsequently converted into phonons (i.e., vibrations of the lattice).
Therefore, the LSPR peak of a metal nanostructure typically includes both scattering and
absorption components.
Interestingly, the resonant frequency and the cross-sections of both scattering and
absorption components are dependent on the size, shape, and chemical composition of the
nanostructure.[9-13] This observation allows one to tune the LSPR features of metal
nanostructures, making such materials potentially useful. For example, Au colloids with
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their LSPR peaks in the visible region have been demonstrated for colorimetric sensing in
the selective detection of heavy metal ions and various biomolecules.[14,15]
The LSPR spectra of nanostructures can be predicted by solving Maxwell’s
equation. In 1908, Gustav Mie solved Maxwell’s equation for solid spherical particles
with dimensions less than the wavelength of light.[16] The formulas derived by Mie can be
used to compute the LSPR spectra (including both scattering and absorption) of a
spherical particle of any size. It was calculated that Au nanospheres 40 nm in diameter
would have an extinction peak centered at 520 nm, whereas smaller Au nanospheres
would be slightly blue-shifted and larger Au spheres would be slightly red-shifted (e.g.,
Au colloids 140 nm in diameter would have an LSPR peak around 650 nm). These
calculations have been validated experimentally, demonstrating the utility of Mie’s
formula for predicting the LSPR spectra of spherical particles. Such computations,
however, also indicate that different types of nanostructure must be fabricated in order to
produce Au nanostructures with their LSPR peaks tuned to the near-infrared.
To this end, researchers have explored the following Au nanostructures: i)
aggregates of spherical nanoparticles;[17,18] ii) nanorods;[19-24] and iii) composite or hollow
nanostructures.[25-31] The third option is particularly interesting as different surfaces
and/or hollow interiors provide a platform for multi-functionalization and encapsulation.
In 1989, Neeves and Birnboim calculated the LSPR spectra for composite spherical
particles (i.e., those consisting of a metal shell and dielectric core such as silica or air)
and found that they would give rise to LSPR modes extending into the near-infrared
region.[32,33] It has, however, been difficult to verify these predictions experimentally.
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Halas and coworkers were among the first to prepare such materials and validated the
calculations of Neeves and Birnboim.[34,35] Halas’ approach to generate Au nanoshells of
variable thickness was to deposit gold onto silica or polymer beads via a direct
deposition/chemical reduction method.[36] While this approach has been used as a general
synthetic route to dielectric/metallic core-shell particles, the preparation of such
composite structures is nontrivial, since most metals do not sufficiently wet the surface of
an oxide or polymeric material.[37] In addition, it is very difficult to obtain a smooth
surface coating, together with accurate control over the shell thickness on the scale of a
few nanometers. Alternatively, the Xia group has recently demonstrated the capability
and feasibility to prepare Au nanostructures with hollow interiors via a galvanic
replacement reaction with Ag nanostructures as a sacrificial template.[38-41] Using this
approach, hollow and porous Au nanostructures can be routinely synthesized from Ag
nanostructures of any morphology.

1.3 Biomedical Applications of Gold Nanostructures
Gold nanostructures are ideal for biomedical applications due to their bio-inert
nature and strong interaction with the thiolate group, allowing for the attachment of a
variety of surface functional groups to enhance circulation in the blood and thus target the
malignant cells in a solid tumor.[42]

Furthermore, the optical properties of these

nanostructures can be readily tailored by controlling their size, shape, composition,
and/or interior (hollow vs. solid),[42-45] so that their LSPR peaks can be tuned into the
near-infrared region (700 to 1200 nm), where soft tissue, blood, and water has minimum
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absorption (Figure 1.2).[46] A wealth of research has been conducted in the development
of Au nanostructures for biomedical research, particularly for the diagnosis and treatment
of cancer.
Cancer is the second leading cause of death in the United States, trailing only
behind heart disease.[47] Despite the recent advances in the treatment of cancer, far too
many cases are diagnosed only after tumors have metastasized. Consequently, patients
with cancer are confronted with a grim prognosis and often need to undergo toxic and
uncomfortable whole-body chemotherapy and/or other radiation treatments.

Early

detection and better treatments of cancer can significantly reduce the number of deaths
caused by cancer. Table 1.1 shows the average five-year survival rates are higher for
several types of cancers when detected and treated at the earlier stages.[48]
Nanofunctional materials are in a unique position to transform the diagnosis, imaging,
and treatment of cancer.[49] The nanoscale is on the appropriate length scale to enter cells
and to interact with similar-sized biomolecules such as proteins and receptor sites. Gold
nanostructures have already been implemented in several applications. For instance,
nanoshells, nanorods, and nanocages have been used as optical contrast agents for optical
coherence tomography (OCT) and photoacoustic tomography (PAT), as well as
photothermal agents for the treatment of cancerous cells in vitro and in vivo.[27-31,50-55]
Gold nanostructures provide a promising platform for the cancer diagnosis and treatment;
however, there are still a number of challenges that need to be overcome to reach clinical
utility.

5

1.4 Scope of This Work
This dissertation presents the synthesis and optical properties of Au
nanostructures for biomedical applications. My work aims to engineer Au nanostructures
with LSPR peaks in the near-infrared region and strong absorption properties for use as
imaging agents and photothermal transducers for the diagnosis and treatment of
cancerous cells.
Chapter 2 discusses the use of the galvanic replacement reaction in generating
hollow nanostructures of gold. It compares the galvanic replacement reactions between
Ag nanocubes and two Au precursors with different oxidation numbers: AuCl2- and
AuCl4-. While both precursors give nanostructures with hollow interiors, the reactions go
through different morphological, compositional, and spectral evolutions with the
progressive addition of each Au precursor. This observation is probably due to the
different reaction stoichiometry: each AuCl4- reacts with three Ag to generate one Au and
two vacancies in the nanostructure template, while AuCl2- reacts with Ag at a 1:1 ratio
and thus leaving no vacancies. The galvanic replacement reaction with AuCl4- produces
Au nanocages while the reaction with AuCl2- generates Au nanoframes. The LSPR
properties of these hollow nanostructures are explored by a combination of discrete
dipole approximation calculation (DDA) and single-nanoparticle spectroscopy. The size,
thickness, and porosity of the nanostructures determined the LSPR peak position as well
as their scattering and absorption cross-section properties.
Chapter 3 focuses on the use of Au nanocages for two-photon photoluminescence
imaging of U87MGwtEGFR glioblastoma cells. Gold nanocages with LSPR peaks in the
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near-infrared region exhibited a broad photoluminescence band extending from 400 to
700 nm when excited with a Ti:sapphire laser. This phenomenon enables me to exploit
Au nanocages as a new class of optical imaging agents for two-photon microscopy. I
demonstrate the use of two-photon microscopy as a simple and convenient tool to
examine the uptake of antibody-conjugated and PEGylated Au nanocages by
U87MGwtEGFR cells. I have also correlated the results from two-photon microscopy
with the data obtained using inductively coupled plasma mass spectrometry. My results
indicate that the antibody-conjugated Au nanocages were bounded to the surface of cells
and then internalized into the cells via receptor-mediated endocytosis. The cellular uptake
process was dependent on a number of parameters, including the incubation time, the
incubation temperature, the number of antibodies immobilized on each nanocage, and the
dimension of the Au nanocages.
Chapter 4 quantifies the photothermal effect of Au nanocages targeted to SK-BR3 breast cancer cells. Gold nanocages with an average edge length of 65±7 nm and a
strong absorption peak at 800 nm are conjugated with monoclonal antibodies (antiHER2) to target SK-BR-3 through the epidermal growth factor receptor (in this case,
HER2), which is overexpressed on the surfaces of the cells. Both the number of immuno
Au nanocages immobilized per cell and the photothermal therapeutic effect are quantified
using flow cytometry. The targeted cells are irradiated with a pulsed near-infrared laser,
and by varying the power density, the duration of laser exposure, and the time of
response after irradiation, I are able to optimize the treatment conditions to achieve
effective destruction of the cancer cells. I found that cells targeted with the antibody-
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conjugated Au nanocages responded immediately to laser irradiation and that the cellular
damage was irreversible at power densities greater than 1.6 W/cm2. The percentage of
dead cells increase with increasing exposure time up to 5 min and then becomes steady.
By quantifying the photothermal effect of immuno Au nanocages, critical information
with regards to both the optimal dosage of nanocages and parameters of the laser
irradiation has been garnered and will be applied to future in vivo studies.
Chapter 5 covers the synthesis of Au microplates in aqueous solutions by
reducing HAuCl4 with the hydroxyl groups in the serine and threonine units of bovine
serum albumin (BSA). I induce structural changes to the protein using temperature, pH,
and ionic strength to expose these hydroxyl groups. I investigate the effects of these
three parameters on the structure of BSA and the synthesis of Au structures. The optimal
experimental condition to produce Au microplates was at elevated temperatures (55 oC),
in acidic conditions (pH ≈ 3), and in the presence of NaCl (0.14 M).

8

Figure 1.1 Schematic illustration of the collective oscillation of free electrons that are
localized in a spherical Au colloid in the electric field of incident light (reproduced from
ref. [7]).

9

Figure 1.2 Absorption spectra of deoxy-hemoglobin (Hb), oxyhemoglobin (HbO2), and
water. The concentrations of Hb and HbO2 are adjusted to 50 mM (reproduced from ref.
[46]).
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Table 1.1 Average Five-Year Survival Rates from Stage of First Diagnosis for Several
Cancer Types (reproduced from ref. [49]).
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Chapter 2

Hollow Nanostructures of Gold

2.1 Introduction
Hollow nanostructures of noble metals (e.g. Au, Pt, and Pd) have gained attention
in recent years for a variety of applications including catalysis,[1] optical sensing,[2] drug
delivery,[3] biomedical imaging[4-6] and photothermal therapy[7-10] due to their tunable
optical properties and large surface areas. Among various synthetic approaches, the
galvanic replacement reaction represents the most versatile route to bimetallic hollow
nanostructures.[1,11-16] Bimetallic hollow nanostructures consisting of Ag and Au, Pt or
Pd have been synthesized by reacting Ag nanostructures (or templates) with a salt
precursor containing a less reactive metal such as Au, Pt or Pd.
In this chapter, I explore the replacement reaction between Ag nanocubes and
AuCl4- or AuCl2- as a robust method for generating hollowing nanostructures in the form
of nanoboxes, nanocages, and nanoframes. There are three main sections in this chapter.
In the first section, I briefly describe the synthesis of Au nanocages via the galvanic
replacement reaction using AuCl4-. This discussion is followed by an account of their
optical properties. In the second section, I study the effect of changing the stoichiometry
of the galvanic replacement reaction by using a Au precursor with a different oxidation
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state, AuCl2-. I report a detailed account of the morphological and optical differences of
the products obtained using the replacement reaction involving Ag nanocubes and AuCl2or AuCl4-. In the third section, I discuss the synthesis of Au nanoframes via the galvanic
replacement reaction using AuCl2-, followed by a discussion of their optical properties.

2.2 Gold Nanocages
Gold nanocages are single-crystalline, hollow structures with porous walls. They
are commonly prepared using the galvanic replacement reaction between Ag nanocubes
and AuCl4-. To prepare Au nanocages, I have to first prepare the sacrificial templates -uniform Ag nanocubes.

2.2.1 Synthesis of Gold Nanocages
The Ag nanocubes are most commonly synthesized using the polyol method,
which involves heating ethylene glycol, AgNO3, and poly(vinyl pyrrolidone) (PVP).[17]
These three components function as the reducing agent/solvent, metal precursor, and
capping agent, respectively. In a typical reaction, ethylene glycol is heated to 150-160 oC
in air to generate glycolaldehyde (Eq. 2.1).[18]
2HOCH2CH2OH + O2 → 2HOCH2CHO + H2O

(2.1)

Glycolaldehyde then reduces the Ag+ ions to Ag atoms which subsequently agglomerate
to form nuclei and seeds. As more Ag atoms are produced, the seeds grow into different
nanostructures depending on their crystallinity. The role of PVP is to direct the addition
of atoms to the {111} facets, due to its stronger binding affinity toward the {100} facets.
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For example, Ag pentagonal nanorods in the presence of PVP will extend to form
nanowires since PVP will bind to the {100} side faces, facilitating the addition of Ag
atoms onto the {111} facets at the ends of the wire.[19] Similarly, in the case of the
single-crystal Ag cubooctahedrons, PVP will block the addition of atoms onto the {100}
side facets, allowing Ag atoms to add onto the {111} corner facets and promoting their
growth into Ag nanocubes with sharp corners.
In order to synthesize nanocubes in high yields, it is crucial to control the
crystallinity of the initial seeds. In one method developed in our group, we selectively
remove twinned seeds by oxidative etching with O2 and Cl-, leaving behind only singlecrystal seeds, which grow into Ag nanocubes.[20] Ag nanocubes of different sizes can be
routinely produced through this etching method, Figure 2.1.

Most recently, I have

demonstrated a much faster method that eliminate the formation of twinned seeds by
increasing the reduction rate of Ag+.[21,22] This process was achieved by introducing a
trace amount (on the ppm level) of Na2S or NaHS to the reaction, producing Ag2S
nanocrystallites that can catalyze the reduction of additional Ag+. This method has
significantly reduced the overall reaction time from 10-24 hours to less than 20 minutes
and is now the most commonly used protocol for producing Ag nanocubes in large
quantities.
The galvanic replacement reaction provides a simple and versatile method for
generating hollow nanostructures with tunable plasmonic properties, such as the Au
nanocages shown in Figure 2.2A.[19,22-26] When an aqueous suspension of Ag nanocubes
with sharp corners is titrated with an aqueous solution of AuCl4-, the galvanic
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replacement reaction between these two species occurs immediately, leading to the
formation of Au-based nanoboxes and eventually porous nanocages.[25] This reaction
follows a template-engaged hollowing out mechanism.[13,25,27,28] Briefly, AuCl4- oxidizes
the sacrificial Ag template to AgCl, which is highly soluble at the boiling temperature
used for the reaction (Eq. 2.2).[29]
3Ag(s) + AuCl4-(aq) → 3 Ag+(aq) + Au(s) + 4Cl-(aq)

(2.2)

The driving force for this reaction originates from the difference in standard
reduction potential for the AuCl4-/Au pair (0.99 V vs. the standard hydrogen electrode,
SHE) and the AgCl/Ag pair (0.22 V). The electrons generated in the oxidation process
migrate to the surface of the Ag cubes and reduce AuCl4- to Au atoms. Gold atoms are
able to epitaxially nucleate and grow on the surface of the Ag template since Au and Ag
share the same face-centered cubic (fcc) structure with closely matching lattice constants
(4.0786 and 4.0862Å, respectively). The morphological details of this reaction will be
further discussed in Section 2.3.

2.2.2 Optical Properties of Gold Nanocages
One of the great advantages of the synthesis based on galvanic replacement
reaction is its ability to precisely tune the LSPR peak of Au nanocages to a specific
wavelength. In this way, the synthesis can be optimized for maximum absorption at the
wavelength needed for a specific laser or application. For biological applications, the
region of interest is in the near-infrared (800-900 nm), where soft tissue and blood are
optically transparent. Figure 2.2B shows that by simply adjusting the amount of AuCl4-
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added, the peak can be shifted controllably from ~450 nm for the 50-nm Ag nanocube
template to ~900 nm when fully transformed into porous Au nanocages. It is easy to
monitor the peak position during the reaction with UV-visible (UV-vis) spectroscopy,
allowing for precise tuning.
It has been shown that the size, wall thickness, and porosity of the hollow
nanostructures all have a strong effect on the absorption and scattering cross-sections.[3035]

To better engineer Au nanocages for biomedical applications, I calculated the

theoretical spectra for a number of different types of cages.

Gustav Mie solved

Maxwell’s equations to generate an exact formula for optical extinction; however, this
method is only limited to geometries with spherical symmetry and is consequently not
suitable for studying Au nanocages.[36] Instead, I use the discrete dipole approximation
(DDA), which has been demonstrated to be reliable for calculating the optical properties
of nanostructures with arbitrary geometries.[32,37,38] The DDA method approximates a
nanostructure as a cubic array of polarizable units that interact both with the incident field
and each other. The resulting polarization at each point can be used to calculate the
overall optical cross-section of the particle at any wavelength, generating simulated
spectra.
Figure 2.3, A and B, compares the calculated extinction (Cext), absorption (Cabs),
and scattering (Csca) coefficients (note that Cext=Cabs+Csca) for Au nanoboxes 60 and 40
nm in edge length, respectively, with the wall thickness being 5 nm.[6] Nanoboxes have
hollow interiors and nonporous walls, whereas nanocages have walls with holes. The
refractive index of bulk Au was used, and the nanobox was assumed to be surrounded by
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and completely filled with water.

As expected from studies of solid Au particles,

absorption dominates the extinction spectra at small sizes (<40 nm), while scattering
dominates at larger sizes (>60 nm). These nanoboxes have absorption cross-sections at
least five orders of magnitude larger than organic chromophores.
Figure 2.3, C and D, shows the influence of reduction in wall thickness and
introduction of pores at corners, respectively. Figure 2.3C shows that the extinction peak
was red-shifted from 710 nm to 820 nm when the wall thickness of the nanobox was
reduced from 5 nm to 3 nm.

Interestingly, the magnitudes of both scattering and

absorption cross-sections only changed slightly.

Figure 2.3D shows the calculated

spectra of a nanobox similar to that used for Figure 2.3B, except that all eight corners
were replaced with holes to form a nanocage. The peak remained roughly at the same
position, though a small reduction in the magnitude of the extinction cross-section was
observed. Further calculations have shown that the extinction coefficient of a 40-nm Au
nanocage linearly decreased with the number of holes.
The calculated spectra match well with what I have observed experimentally with
the solution-phase spectra of nanoboxes; the slight broadening of the peak seen in the
experimental data can be attributed to the minor differences in the uniformity of the
nanostructures (i.e., size, levels of truncation, and wall thickness). These insights into the
effect of size, wall thickness, and porosity should allow us to more effectively tune the
optical properties of nanocages.

2.3 A Comparative Study of Galvanic Replacement Reactions Involving
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Ag Nanocubes and AuCl2- or AuCl4According to the stoichiometry between Ag and AuCl4- (Eq. 2.2), only one Au
atom is formed for every three Ag atoms that are removed. If the AuCl4- is replaced with
a precursor such as AuCl2-, the stoichiometry will be changed due to the difference in
oxidation number for gold. For the Au(I) precursor, one Au atom will be formed for
every Ag atom being oxidized. This change to the amount of Ag consumed relative to
the amount of Au generated during the reaction could impact the alloying and dealloying
processes. It is also possible that additional flexibility regarding the morphology, wall
thickness, and LSPR position of resultant hollow nanostructures could be achieved by
using precursors with different oxidation numbers for gold. Herein I report a detailed
study of the galvanic replacement reaction between Ag nanocubes and AuCl2- in a close
comparison with the reaction involving AuCl4-. Because the standard reduction potential
of the AuCl2-/Au pair (1.11 V vs. SHE) is higher than that of the AgCl/Ag, Ag nanocubes
can be oxidized by AuCl2- (Eq. 2.3).[39] In addition, AuCl2- reacts with Ag to form the
same products as the reaction between AuCl4- and Ag, thus providing a meaningful
comparison for the galvanic replacement reactions involving Au(I) and Au(III)
precursors.
Ag ( s ) + AuCl2− (aq) → Au ( s ) + AgCl ( s ) + Cl − (aq )

(2.3)

The Ag nanocubes used as the sacrificial template were synthesized using a
sulfide-mediated polyol process, described earlier in the chapter, and had a mean edge
length of 52 ± 4 nm.[21,22] The galvanic replacement reaction using with AuCl2- was
similar to the reaction using AuCl4-, except that due to the low solubility of AuCl in
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water, a saturated aqueous solution of NaCl was used to dissolve the AuCl through
complexation to form water soluble NaAuCl2 species. Note that the presence of excess
NaCl in the reaction solution will also make the AgCl soluble by forming a AgCl2complex. I only used freshly prepared AuCl2- solutions to avoid its disproportionation,
(Eq. 2.4):

3 Au ( I ) → 2 Au (0) + Au ( III )

(2.4)

2.3.1 Morphological Comparison
Figure 2.4 shows scanning electron microscopy (SEM) and transmission electron
microscopy (TEM) images of the nanostructures obtained at different stages of the
reactions between Ag nanocubes and an aqueous AuCl2- solution (Figure 2.4, A-D). For
comparison, SEM and TEM images of the products obtained with the use of AuCl4solution at the same concentration are also included (Figure 2.4, E-H). For each stage,
the volume of AuCl4- solution added to the Ag nanocube suspension was kept at 1/3 of
the volume of AuCl2-, so that ideally the same amount of Ag would be dissolved from the
template. At the initial stage of the reaction with AuCl2-, the Ag nanocubes went through
a pitting process in which a pinhole in one of the six {100} faces was observed (Figure
2.4A). As the reaction proceeded, the pinhole disappeared and a void developed which
then enlarged within each nanocube template (Figure 2.4, B and C). In the later stages of
the reaction, the template was transformed into a cubic void, yielding nanoboxes with a
wall thickness of 10.5 ± 1 nm (Figure 2.4D). The outer and inner edge lengths of the
nanoboxes were 64 ± 4 nm and 43 ± 4 nm, respectively. The hollow structures were free
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of large pores or pinholes in the walls, and the corners were slightly truncated.
For the control experiments involving Ag nanocubes and AuCl4-, the reaction
followed the same mechanism that has been discussed in detail in our previous
publications.[25] At the early stage, a thin layer of gold formed on the outside of the
nanocube and a small pit was observed on one of the six {100} faces (Figure 2.4E). As
more AuCl4- solution was added, the interior of the template continuously dissolved to
yield a nanobox through a combination of galvanic replacement and alloying between Ag
and Au (Figure 2.4, F and G).

In the later stages, nanocages, with hollow interior and

porous walls, were obtained through dealloying of the walls of the nanoboxes (Figure
2.4H). The outer edge length of the nanocages was 60 ± 4 nm, together with a wall
thickness of 8 ± 1 nm. On a quick comparison, it is apparent that some morphological
differences have resulted from the use of precursors with different oxidation numbers for
gold.
Figure 2.5 schematically summarizes the replacement reaction pathways when Ag
nanocubes are reacted with AuCl2- (Figure 2.5A) and AuCl4- (Figure 2.5B), respectively.
During the initial stage of both reactions, a thin layer of Au is formed on the surface of
the nanocube template.

Assuming that the deposited layer of Au can prevent the

underneath Ag from being oxidized, a pinhole can serve as the active site for Ag
dissolution from the interior of the template. With AuCl2-, the pinhole disappears with
the addition of only a small amount of precursor, marking the second stage of the
reaction. In contrast, with AuCl4-, the pinhole remains open until much more precursor is
added in the third stage of the reaction. The early disappearance of the pinhole for the

24

reaction with AuCl2- can be attributed to the 1:1 molar ratio between Au generated and
Ag consumed; i.e., more Au(0) is deposited per Ag atom being oxidized than the case
when AuCl4- is used. Consequently, dissolution of the Ag template for the reaction with
AuCl2- requires a greater volume of precursor solution (stage 4 versus stage 3 in Figure
2.5) than when AuCl4- is used because there is no pinhole for the reaction species to
diffuse in and out for the former system. Instead, the Ag atoms must diffuse through the
Au layer in order to be oxidized and dissolved from the template. Concurrent with the
replacement reaction, alloying between Au and Ag occurs because the diffusion rates of
Au and Ag are relatively high at 100 oC[40] and the Au/Ag alloy is more stable than pure
Au or Ag.[41]
The hollow nanostructures obtained from the reactions with AuCl2- and AuCl4exhibit similar void sizes after the fourth stage, although for both cases the void sizes are
smaller than the original Ag template. The difference between the dimensions of the void
and the initial Ag template can be attributed to the interdiffusion between Ag and Au; i.e.,
Ag diffuses away from the core and toward the surface of the template as Au diffuses into
the Ag layer. This interdiffusion causes a ~20% reduction for the void size as compared
to the dimensions of the Ag nanocube. A similar size change has been reported in
nanostructure systems involving the Kirkendall effect.[16,42,43] In these systems, vacancies
are formed due to a difference in diffusion rate for the two components. Although
interdiffusion between Au and Ag occurs in my system as well, the formation of a hollow
interior can be primarily attributed to the template-engaged replacement reaction where
Ag leaves the template due to oxidation. As proposed in the void growth process via
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Kirkendall-diffusion, small voids are formed near the interface, which then grow in size
over time via coalescence.[16,42,43]

I have not observed this behavior in the Au/Ag

galvanic replacement reaction system. Rather, the void is initiated at the pinhole site and
then enlarged to occupy the entire template.

2.3.2 Optical Differences
In addition to the morphological changes, the galvanic replacement reaction
between Ag nanocubes and AuCl2- went through a series of color changes from yellow to
orange, red, purple, and finally blue, in a sequence similar to the reaction with AuCl4-.
The UV-vis spectra taken from these solutions, however, reveal a somewhat different
shift in peak position (Figure 2.6). For the reaction between Ag nanocubes and AuCl2-,
the extinction peak shifted from 435 nm to 655 nm as more AuCl2- was added (Figure
2.6A). When the same stoichiometric volume of AuCl4- (3 times the amount of AuCl2-)
was added to Ag nanocubes, the extinction peak continuously shifted to 780 nm for the
reaction with AuCl4- (Figure 2.6B). Also, the peaks of the UV-vis spectra recorded from
the reaction with AuCl2- were broader than that of AuCl4-. Based on the TEM images
shown in Figure 2.4, A-D, this peak broadening is probably related to a wider range of
void sizes in the resultant hollow nanostructures. Because of the early disappearance of
the pinhole for the reaction with AuCl2-, the removal of Ag relies more on Ag diffusion to
the surface, thus causing a broader distribution for both void size and wall thickness. As
shown previously by DDA method, any variation in wall thickness may result in
broadening for the LSPR peak. Figure 2.6C plots the peak position versus the amount of
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Au precursor added to the reaction solution. For the early stages of both AuCl2- and
AuCl4-, the peak position red-shifted considerably upon addition of the Au precursor.
The pitting process strongly influences wall thickness, resulting in a dramatic change in
the LSPR peak position. As more solution was added, the plot tapered in the later stages.
This trend supports previous DDA calculations that thickness has a dramatic effect on
peak position and that the number of holes in the wall has little effect on the peak
position.[6,11] It is also worth pointing out that the overall slope for AuCl4- is steeper than
that of AuCl2- signifying that AuCl4- red-shifted the extinction peak more effectively
(with less precursor solution) than AuCl2-.

Consequently, AuCl4- provides a more

economical way to red-shift the LSPR peak position. Overall, AuCl4- is better than
AuCl2- at tuning the LSPR scope because it provides a wider range of peak positions due
to its ability to dealloy and form thinner walls. On the other hand, AuCl2- is a better
choice for the preparation of Au-based nanoboxes without pores in the walls because
there is a relatively larger range compared to AuCl4- where the amount of precursor can
form nanoboxes.

2.3.3 Effects of Dealloying
I also studied the late stages of the galvanic replacement reaction with AuCl2-. As
reported in previous publications,[13,25,27,28] during the later stages of the galvanic
replacement reaction with AuCl4-, a dealloying process takes place, allowing Ag to be
removed from the Au/Ag alloyed walls. The resultant lattice vacancies formed during the
extraction of Ag atoms cause negative curvatures and thus an increase in interfacial area
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and surface energy for the solid walls.[44]

This stress can be released by shape

reconstruction, probably via an internal Oswald ripening process,[45] resulting in each
corner of the nanobox being truncated to form a new face enclosed by the {111}
crystallographic planes to lower the surface energy. A different reconstruction was
observed for the later stages of the replacement reaction when AuCl2- was used as a
precursor. As more AuCl2- solution was added to the suspension of nanoboxes with
slightly truncated corners (Figure 2.7A), the center of the faces became porous and
nanoframes with edge length 61 ± 3 nm and thickness about 17 ± 2 nm were obtained
(Figure 2.7B). The formation of nanoframes contrasts with that of nanocages synthesized
from the reaction with AuCl4-, and this difference in morphology is again related to the
amount of Au(0) being deposited per each Ag(0) dissolved. In the case of AuCl4-, only
one Au(0) atom is formed per every three Ag(0) atom. As a result, the nanocages formed
during the dealloying process have extremely thin ridges, which quickly fall apart into
discrete nanoparticles. On the other hand, AuCl2- generates one Au(0) atom per Ag(0)
atom, thus making the ridges of nanocages thicker and more robust to survive the
dealloying process. Only when an extreme amount of AuCl2- solution was added (22
mL), regions of the nanoframes became globular and fragmented from the structures to
form solid Au nanoparticles (Figure 2.7C). The UV-vis spectra of these products show
that the addition of AuCl2- blue-shifted the LSPR peak from 680 to 550 nm. Energydispersive X-ray (EDX) data showed that Ag was still present in the last sample,
suggesting that the AuCl2- was unable to reach the Ag trapped inside the particle, thus
complete dealloying could not occur even with an excess of AuCl2-.
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In the case of

AuCl4-, as more solution was added (5 mL), the dealloying process continued until
essentially all the Ag in the alloyed walls was removed. In fact, the walls of the Au
nanocages became so porous and fragile that the cages started to shatter into small pieces
(Figure 2.8). EDX measurements indicate that these fragments were made entirely of
gold.
Table 2.1 summarizes the EDX data taken from the hollow nanostructures
obtained at different stages of the reaction. Generally, the percentage of Au increased as
more AuCl2- or AuCl4- solution was added into the reaction. At the early stages, the
increase of Au content in the products obtained from the reactions with AuCl2- was
higher than AuCl4-. This result is expected as more Au should be generated from the
reaction with AuCl2- than with AuCl4- (at a 3:1 ratio) when the amount of Ag oxidized is
held constant. However, at the late reaction stages, this trend is reversed. For instance,
when 10 mL of AuCl2- solution was added, the product was composed of 59% Au and
41% Ag, whereas for the product obtained from the reaction with 3.3 mL of AuCl4-, there
was 72% Au and 28% Ag. These results confirm that more Ag can be removed via
dealloying of the Au/Ag alloyed walls by AuCl4- than by AuCl2-.

2.4 Gold Nanoframes
Previously, cubic Au nanoframes were synthesized by our group in a two-step
process, in which a wet etchant such as Fe(NO3)3 or NH4OH was used for the selective
removal of Ag from the Au-Ag alloy nanostructures after thin layers of Au have been
deposited onto the surfaces of Ag nanocubes.[46] This procedure tended to greatly reduce
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the wall thickness and causes pores to form on the side faces. At a certain point of the
reaction, the pores on each side face could coalesce into a single large hole, leading to the
formation of a cubic nanoframe, a structure that was not previously achieved with AuCl4alone. However, if this specific point was passed during the synthesis, the Au nanoframe
would break into small pieces because the ridges became too thin and fragile. The Au
nanoframes formed via this route were so sensitive to the reaction details that the reported
yield never exceeded 5-10%. Conversely, when AuCl2- is employed as a precursor to Au
instead of AuCl4-, nanoboxes with thicker walls can be generated due to the
stoichiometric difference.[47]

I postulated this method would improve the yields of

nanoframes by increasing the thickness (and thus robustness) of ridges that support the
nanoframes. Here I present the facile, one-step synthesis of Au nanoframes with a typical
yield of >90%.

2.4.1 Synthesis of Gold Nanoframes
The synthesis of Au nanoframes was based upon the galvanic replacement
reaction between Ag nanocubes and AuCl2-. The Ag nanocubes with an average edge
length of 52±4 nm were synthesized by a sulfide-mediated polyol process[21,22] as
described earlier in this chapter. The Ag nanocubes then served as a sacrificial template
for the formation of Au nanoframes. Figure 2.9 shows SEM and TEM (inset) images of
samples obtained at different stages of the galvanic replacement reaction and Figure 2.10
shows a schematic that summarizes this process. In the initial stage, Au deposited on the
surface of the Ag cube and a pinhole formed on one of the six side faces, allowing for the

30

exchange of atoms during the pitting process (Figure 2.9A, and step A in Figure 2.10).
Shortly after, the pinhole closed, generating a partially hollow structure (Figure 2.9B, and
step B in Figure 2.10). The interior of the nanostructure continued to be hollowed out as
Ag atoms diffused to the surface of the structure and Au diffused into the structure,
leading to the formation of a seamless Au nanobox with slightly truncated corners
(Figure 2.9C, and step C in Figure 2.10). This shape reconstruction marked the start of
dealloying, where the vacancies from the extraction of Ag atoms caused negative
curvatures, resulting in an increase in interfacial area and surface energy for the solid
walls.[44] This stress was relieved via an internal Ostwald ripening process and new
{111} facets were formed.[45] Since the relative surface energies of different facets are in
the order of γ111 < γ100 < γ110 for a fcc metal,[48,49] truncated boxes with a larger portion of
{111} facets should be more stable than those with sharp corners. The formation of a
truncated rather than a perfect cubic shape had also been observed in many other
systems.[50,51] Concurrent to the replacement reaction (i.e., Figure 2.9A-C, and steps A-C
in Figure 2.10), the rates of diffusion for Ag and Au were accelerated by the relatively
high reaction temperature at 100 oC[40] and subsequently forming a Au-Ag alloy that is
more stable than pure Au or Ag alone.[41] When more AuCl2- was added, the removal of
Ag and deposition of Au occurred at all sites, and pores appeared at corners and side
faces (Figure 2.9D, and step D in Figure 2.10). As dealloying continued, the pores on the
side faces enlarged while the pores at the corners reduced in size (Figure 2.9E, and step E
in Figure 2.10), suggesting that the atoms migrated to the more stable {111} facet.
Eventually, the pores at the corners were sealed while the pores on all side faces were
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enlarged to the maximum size, resulting in the formation of a cubic nanoframe (Figure
2.9F, and step F in Figure 2.10). This point is the critical for harvesting Au nanoframes
with a yield approaching 100%. When more AuCl2- was added, the ridges would become
thinner due to dealloying of Ag atoms from the structure (Figure 2.9G, and step G in
Figure 2.10). At a certain point, the ridges became too thin to support the open structure
that the nanoframes fragmented and finally evolved into Au nanoparticles (Figure 2.9H,
and step H in Figure 2.10).
The SEM image in Figure 2.11A shows Au nanoframes with an average edge
length of 63±4 nm and ridge thickness of 19±2 nm that were synthesized under the same
condition as for Figure 2.9F. The elemental composition of these nanoframes was
determined to be 89% Au and 11% Ag by EDX analysis.

To better resolve the three-

dimensional structure of the nanoframes, the sample was tilted by 45o as shown in Figure
2.11B. Figure 2.11C shows a TEM image of the nanoframes, from which one can easily
resolve the hollow structures and determine the thickness of the ridges. Figure 2.11D
shows a high-resolution TEM image of a corner of the nanoframe taken along the [001]
zone axis. This image indicated that the atoms were arranged in a highly ordered lattice
with a spacing of 2.04 Å, which can be indexed to the {200} planes of fcc Au. The fast
Fourier transform (FFT) pattern revealed that the nanoframe was single crystalline in
structure.

The spots circled and squared can be indexed to the {220} and {200}

reflections, respectively.

2.4.2 Optical Properties of Gold Nanoframes
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Figure 2.12A summarizes the UV-vis spectra of the structures shown in Figure
2.9, A-F. As more AuCl2- was added, a significant red-shift was observed. The UV-vis
spectrum of the Au nanoframes (Figure 2.11) had an LSPR peak around 790 nm. The
broadness of the peak may be ascribed to the variations in edge length, ridge thickness,
and corner sharpness.

Potential applications such as imaging, SERS, chemical and

biological sensing are dependent upon LSPR properties; therefore, it is important to
understand the relationship between these variations and LSPR properties to effectively
tune the resonance peak. As it has been established for Au or Ag nanostructures of other
shapes, the LSPR property of a nanoframe should depend on several factors including the
edge length, ridge thickness, corner sharpness, elemental composition, laser orientation
and environment.[6,21,38,52-55] To determine how these factors, specifically the size and
shape, influence the LSPR peak, the scattering spectra of individual nanoframes were
calculated using the DDA method.

After reviewing many spectra, I found a trend

between the peak position and the edge length to ridge thickness ratio, R. Figure 2.12B
shows the spectra calculated for nanoframes with an edge length of 57.0, 59.4, 61.7, 64.1,
66.5, and 68.9 nm, while keeping a composition of 89% Au and 11% Ag.

The

nanoframes were assumed to have sharp corners as shown in the inset. As the R value
increased, the peak position red-shifted while the peak intensity slightly increased.
Figure 2.12C shows the DDA calculated extinction, absorption and scattering spectra for
the nanoframe with R=3.37 and geometry as shown in the inset.
To confirm the theoretical calculations, nanoframes were deposited on indium tin
oxide (ITO)-coated glass substrates and the scattering spectra of single nanoframes were
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collected using an inverted microscope with a transmitted dark-field condenser as
previously described.[56-58] The scattering spectra are plotted in Figure 2.12D along with
their corresponding SEM images in the inset. I observed that the spectra red-shifted as
the R value increased, validating the trend found by DDA calculation. This result was
expected as a decrease in ridge thickness or increase in edge length would increase the
charge separation, thus reducing the restoring force for electron oscillation and resulting
in red-shifting for the resonance peak. As previously reported for hollow nanospheres,
thinner shells have stronger coupling between charges inside and outside of the shell,
causing greater charge separation and further red-shift in peak position.[38] Similar to the
calculated spectra, the peak intensity was higher for larger R values, and this trend was
expected as larger particles scatter more light.
It is worth pointing out that the resonance peaks for the calculated spectra did not
completely match the experimental spectra, which can be ascribed to the complexity of
the structure. In the ideal situation, a nanoframe has uniform pore size, ridge thickness,
edge length in addition to sharp corners as seen in the inset of Figure 2.12B. From the
electron microscopy images in Figures 2.11 and 2.12D, it is clear that within one
nanoframe there are variations in these features which would result in some shifts for the
resonance peak. Additionally, it has been previously shown that the substrate can shift
the LSPR peak.[54] Since the DDA calculations of the nanoframes were performed for
particles suspended in water, I expect some shifts due to the substrate effect.
The Au nanoframes can also serve as substrates for SERS based detection. Due to
their tunable LSPR peaks into the near-infrared region, they are ideal candidates for
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detection of molecules in vivo, as the light source in this region can penetrate deeply into
soft tissue. As a demonstration of their SERS application, the Au nanoframes were
functionalized with 4-methylbenzenethiol (4-MBT, a common probe molecule for SERS)
and their SERS spectrum was recorded in a solution phase setup. Figure 2.13 shows the
SERS spectrum for the Au nanoframes functionalized with 4-MBT (spectrum A) along
with the ordinary Raman spectrum of 4-MBT (spectrum B), both obtained with excitation
at 785 nm. As illustrated in Figure 2.13, the utilization of the Au nanoframes lead to a
significant enhancement on the intensity of the 4-MBT signals compared to the spectrum
of neat 4-MBT, indicating that they are good substrates for SERS. However, an accurate
estimation of the enhancement factor is limited by the complex morphology of the Au
nanoframes, which makes it difficult to precisely determine their surface area and,
consequently, the number of 4-MBT molecules contributing to the detected SERS
signals.

2.5 Summary
Gold nanocages can be routinely prepared via the galvanic replacement reaction
between Ag nanocubes and AuCl4-.

By controlling the size of Ag nanocubes, Au

nanocages of different sizes can be produced routinely in high yields. The optical
properties of these nanocages can also be tailored, allowing for the peak absorption to be
precisely tuned well into the near-infrared region by simply titrating AuCl4- into a
solution of Ag nanocubes. DDA calculations suggest that the observed red-shift of the
LSPR peak with increasing AuCl4- is mainly due to a reduction in wall thickness. The
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DDA calculation clearly indicate that these Au nanocages strongly absorb and scatter
light in the near-infrared region, with their absorption cross-sections more than five
orders of magnitude larger than those of conventional dyes. Gold nanocages provide a
promising platform for the imaging and photothermal treatment of cancer due to their
unique optical properties, bio-inertness, and facile surface chemistry. I discuss these
biomedical applications in Chapters 3 and 4.
Furthermore, I have demonstrated that a change of stoichiometry between Au
deposition and Ag oxidation in galvanic replacement reaction can lead to differences in
the morphology, composition, and optical properties of the resultant hollow
nanostructures.

When Ag nanocubes were reacted with either AuCl4- or AuCl2-,

nanoboxes with a hollow interior and a Au/Ag alloy shell were formed at the early stages
of reaction. Thicker walls, however, were observed for the nanoboxes obtained from the
reaction with AuCl2- compared to AuCl4-.

In later stages of replacement, AuCl4-

dealloyed Ag from the walls of the Au/Ag alloy nanoboxes and formed porous
nanocages. Interestingly, Au nanoframes with a yield >90% were synthesized in the
reaction with AuCl2-. The thicker and more robust structure could survive during the
dealloying stage to form Au nanoframes. I have also characterized the effect of the
dimensional parameters of Au nanoframes on the positions of their LSPR peak. Due to
their highly open structure, the nanoframes are potentially useful for SERS detection of
analytes such as virus and bacteria with relatively large dimensions.

2.6 Experimental Section
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Synthesis of Ag nanocubes. The Ag nanocubes were prepared using the sulfide-

mediated polyol process.[21,22] In a typical synthesis, 6 mL EG (J. T. Baker, 9300-03) was
preheated to 155 oC for 1 h under magnetic stirring. EG solutions containing 3 mM Na2S
(Aldrich, 208043), 0.18 M PVP (as calculated in terms of the repeating unit, Mw~55,000,
Aldrich, 856568) and 0.28 M AgNO3 (Aldrich, 209139) were prepared. 80 μL of the
Na2S solution was injected into the hot EG, followed by 1.5 mL of the PVP solution and
then 0.5 mL of the AgNO3 solution. The reaction underwent color changes from yellow
to reddish brown to opaque green-gray with plating on the vial walls. The reaction was
completed within 20 min. The reaction solution was diluted with acetone, and the
product was isolated by centrifugation. The product was washed twice with deionized
water and then collected by centrifugation at 13,000 rpm for 5 min and re-dispersed by
brief sonication in 4 mL of deionized water.
Synthesis of Au Nanocages. The Au nanocages were prepared using the galvanic

replacement reaction between Ag nanocubes and AuCl4-. In a typical synthesis, 50 μL of
Ag ~3.5 nM nanocubes was dispersed in 5 mL of deionized water containing 1 mg mL-1
PVP in a 50 mL flask under magnetic stirring and then heated to boil for 10 min. In the
meantime, a 0.2 mM AuCl4- (Aldrich, 520918) was prepared. A specific amount (as
indicated in the text) of the AuCl4- was added to the flask via a syringe pump (Stoelting,
KDS-200) at a rate of 45 mL h-1 under magnetic stirring. The solution was heated for
another 10 min until the color of the reaction was stable.

Once cooled to room

temperature, the sample was washed with NaCl-saturated solution to remove AgCl and
then with water several times to remove PVP and NaCl. The product was then collected
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by centrifugation at 10,000 rpm and redispersed in water. The product was subsequently
imaged by SEM and TEM.
Synthesis of Au nanoframes.

The Au nanoframes were prepared using the

galvanic replacement reaction between Ag nanocubes and AuCl2-. In a typical synthesis,
50 μL of Ag ~3.5 nM nanocubes was dispersed in 5 mL of deionized water containing 1
mg mL-1 PVP in a 50 mL flask under magnetic stirring and then heated to boil for 10 min.
In the meantime, a NaCl-saturated aqueous solution of 0.2 mM AuCl (Aldrich, 481130)
was prepared. AuCl was washed three times with chloroform to remove Au(III) and
thoroughly dried in the vacuum prior to usage. A specific amount (as indicated in the
text) of the NaCl-saturated AuCl was added to the flask via a syringe pump (Stoelting,
KDS-200) at a rate of 45 mL h-1 under magnetic stirring. The solution was heated for
another 10 min until the color of the reaction was stable.

Once cooled to room

temperature, the sample was washed with NaCl-saturated solution to remove AgCl and
then with water several times to remove PVP and NaCl. The product was then collected
by centrifugation at 10,000 rpm and redispersed in water. The product was subsequently
imaged by SEM and TEM.
Electron Microscopy and Spectroscopy Characterization. SEM or TEM samples

were prepared by placing a drop of the final product on a silicon wafer or carbon-coated
copper grid, respectively, and drying under ambient conditions. SEM images and EDX
data were taken using a Sirion XL field-emission microscope operated at an acceleration
voltage of 10 kV. TEM imaging was performed using a Phillips CM100 microscope
operated at 100 kV. The UV-vis spectra were obtained using a Varian Cary 50 UV-vis
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spectrophotometer.
Substrate Preparation for Optical Characterization. ITO-coated glass substrates

(Thin Film Devices Inc.) were cleaned by sonication in acetone and then isopropanol for
30 min in each solution and then dried under a nitrogen stream. The substrates were then
plasma cleaned (Harrick Plasma, PDC-32G) for 3 min with an applied power of 18 W
before immersing in a solution of 1 mM 3-mercaptopropyltrimethoxysilane in ethanol for
4 h. The substrates were then rinsed with ethanol and cured at 90 °C under nitrogen for
another 4 h, and thereafter stored at room temperature. Before deposition, the stock
solution of Au nanoframes was sonicated for 30 sec. The nanoframes were diluted 20X
with water. The Au nanoframes were allowed to bind onto the surface for approximately
2 min, for a final particle density of ~10 particles per 100 μm2. After depositing, the
excess particles were extensively rinsed off the surface, and the substrate was soaked in
water for 20 min to remove excess PVP, rinsed in water, and finally dried by nitrogen
stream. Scattering spectra were taken with an inverted microscope (Nikon, TE2000) with
a transmitted dark-field condenser and 75X effective magnification as previously
described.[57-59] After optical measurements, the same Au nanoframes were identified
and imaged under SEM with the assistance of registration marks.[52,55,57] This allows us
to correlate the optical spectra to the structural and dimensional information obtained
from SEM imaging.
Surface-Enhanced Raman Scattering Measurements. The SERS spectrum was

obtained from aqueous solution using a Renishaw inVia Raman spectrometer coupled to
a Leica DMIRB inverted optical microscope.
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A diode laser with an excitation

wavelength 785 nm was used at a power of 4.5 mW. The backscattered Raman signals
were collected on a charge-coupled device detector thermoelectrically cooled to -60 oC.
Sample cells were constructed by trimming the bottoms of plastic micro-centrifuge tubes
and affixing the top portions to glass cover slips of thickness between 0.13-0.17 mm.
Solution for SERS measurements were prepared by dispersing the Au nanoframes in 1.5
mL of 5 mM ethanolic solution of 4-MBT for 3 h prior to the SERS measurements,
followed by successive rounds of centrifugation and washing with ethanol to remove
excess 4-MBT. The sample was dried under ambient conditions to remove ethanol and
then re-dispersed in 100 μL of water. The ordinary Raman spectrum of 4-MBT was
obtained from a 100 mM solution in 12 M aqueous NaOH. To ensure that the focal
volume was held constant, a motorized Z-stage with an accuracy of 0.1 μm was used to
control the focal depth. This step was done by focusing the interface between the glass
and the solution, and then using the motorized stage to adjust the focal plane 50 μm into
the solution. Scattering spectra were recorded from 800 to 2000 cm-1 by using a grating
with 1200 lines per millimeter, a spot size of approximately 1.6 μm, and 30 sec
accumulation time.
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Figure 2.1 Synthesis of Ag nanocubes based on the polyol reduction coupled with an

oxidative etching process. SEM images of Ag nanocubes with various sizes: (A) 30 nm;
(B) 50 nm; (C) 90 nm; and (D) 110 nm.
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Figure 2.2 Galvanic replacement between Ag nanocubes and AuCl4-. (A) SEM and

TEM (inset) images of typical Au nanocages obtained from this synthesis. (B) The
optical resonant peak of Au nanocages can be tuned to different wavelengths depending
on the amount of AuCl4- added.
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Figure 2.3 Extinction, absorption, and scattering spectra calculated using the DDA

method for Au nanocages having four different sets of geometric parameters: (A) a Au
nanobox of 50 nm in inner edge length and 5 nm in wall thickness; (B) a Au nanobox of
30 nm in inner edge length and 5 nm in wall thickness; (C) the same as in (B) except that
the wall thickness 3 nm; (D) the same as in (B) except that the eight corners are decorated
with pores of 5 nm in edge length.
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Figure 2.4 SEM and TEM (insets) images showing four different stages involved in the

galvanic replacement reaction where Ag nanocubes were titrated with (A-D) 1.0, 3.0, 5.0,
10.0 mL of 0.1 mM AuCl2- and (E-H) 0.3, 1.0, 1.6, 3.3 mL of 0.1 mM AuCl4-,
respectively. The scale bar in the inset represents 50 nm and applies to all TEM images.
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Figure 2.5 Schematic detailing the major differences in terms of morphological and

structural changes during the galvanic replacement reaction involving Ag nanocubes and
(A) AuCl2- and (B) AuCl4- in an aqueous medium. The cross-sectional view corresponds
to the plane along the dashed lines.
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Figure 2.6 UV-vis spectra of the samples obtained by titrating Ag nanocubes with

different volumes of 0.1 mM solution of: (A) AuCl2- and (B) AuCl4-, respectively. (C) A
plot of the peak position versus the volume of Au precursor, suggesting that AuCl2- has a
smaller shift (as seen by the gradual slope increase) compared to AuCl4- for the same
volume of Au precursor added to the reaction solution.
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Figure 2.7 SEM and TEM (insets) images showing samples obtained in the later stages

of the galvanic replacement reaction where Ag nanocubes were reacted with (A) 12.5
mL, (B) 15.0 mL and (C) 22.0 mL of 0.1 mM AuCl2-. The scale bar in the inset
represents 50 nm and applies to all TEM images. The corresponding UV-vis spectra of
the products are shown in (D).
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Figure 2.8 SEM and TEM (inset) images showing the product obtained in the late stage

of the galvanic replacement reaction where Ag nanocubes were reacted with 5.0 mL of
0.1 mM AuCl4-. The scale bar in the inset represents 50 nm for TEM image.
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Table 2.1 The weight percentage of Au by EDX in the Au/Ag nanostructures obtained

by titrating Ag nanocubes with different amounts of 0.1 mM AuCl2- or AuCl4-.

-

-

AuCl2

Au composition

AuCl4

Au composition

[mL]

[Wt %]

[mL]

[Wt %]

1.0

13

0.3

7

3.0

26

1.0

18

5.0

38

1.6

43

10.0

59

3.3

72

15.0

81

5.0

100

22.0

94

49

Figure 2.9 SEM and TEM (insets) images showing different stages of the galvanic

replacement reaction where Ag nanocubes were titrated with different volumes of 0.2
mM AuCl in 1 mL increments ranging from (A) 1 mL to (H) 8 mL. The scale bar in the
inset represents 100 nm and applies to all TEM images.
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Figure 2.10 A schematic detailing the mechanism of the galvanic replacement reaction

between Ag nanocubes and AuCl2-. The cross-sectional view corresponds to the plane
along the dashed lines. The major steps of the reaction include the following: (A)
formation of a pinhole at one of the side faces, (B) continuation of the replacement
reaction resulting in a partially hollow structure, (C) development of a seamless nanobox
with truncated corners, (D) generation of pores at the corners and side faces by
dealloying process, (E, F) enlargement of pores at the side faces accompanied by
shrinkage of pores at the corners via migration of atoms to the corners, (G) reduction of
the ridge thickness and (H) fragmentation of the nanoframes.
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Figure 2.11 Electron microscopy characterization of the Au nanoframes prepared by the

galvanic replacement reaction between 50 μl of Ag nanocubes and 6 mL of 0.2 mM
AuCl2-: (A) SEM image of the Au nanoframes and (B) the same sample tilted by 45o. (C)
TEM image of the Au nanoframe. (D) High-resolution TEM image of a corner of the Au
nanoframe taken from the region as labeled in the inset. The scale bar in the inset
represents 20 nm. The lattice spacing of 2.04 Å can be indexed as the {200} planes of
Au. In the FFT pattern, the spots circled and squared can be indexed to the {220} and
{200} reflections, respectively.
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Figure 2.12 (A) UV-vis spectra taken from aqueous suspensions of the structures in

Figure 1, A-F, which were synthesized by titrating Ag nanocubes with 1 mL to 6 mL of
0.1 mM AuCl2-. (B) DDA-calculated scattering spectra for nanoframes with an edge
length of 57.0, 59.4, 61.8, 64.1, 66.5, and 68.9 nm, respectively, while the ridge thickness
was kept at 19 nm, together with a composition of 89% Au and 11% Ag. The inset
shows a drawing of the nanoframe used in these calculations, which has both sharp
corners and edges. The plasmon resonance peak red-shifts with increasing the ratio (R)
between the outer edge length (l) and the ridge thickness (t). (C) DDA-calculated
extinction, scattering, and absorption spectra for a nanoframe with R=3.37.

(D)

Scattering spectra of individual Au nanoframes and the corresponding SEM images. For
DDA calculation in (C) and (D), the nanoframes were filled and surrounded by water.
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Figure 2.13 (A) The SERS spectrum taken from Au nanoframes whose surface had been

derivatized with 4-MBT. (B) The ordinary Raman spectrum of 4-MBT (0.1 M in 12 M
aqueous NaOH) taken for reference. The measurements were performed in a solution
phase with an excitation wavelength of 785 nm.
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Chapter 3

Quantifying the Cellular Uptake of Antibody-Conjugated Gold
Nanocages by Two-Photon Microscopy and Inductively
Coupled Plasma Mass Spectrometry

3.1 Introduction
Gold nanocages have recently received increasing interests in biomedical imaging
for modalities such as OCT and PAT. For imaging of cancerous tissue, it is important for
the Au nanocages to have the capability to selectively target cancer cells rather than
healthy cells. Antibodies are one class of commonly used ligands that can be easily
conjugated to the surface of Au nanocages (and other types of nanostructures) for
targeting the receptors typically overexpressed on the surface of cancer cells with high
specificity. To this end, a quantitative understanding of the cellular uptake of antibodyconjugated Au nanocages in vitro can provide useful information for the design,
synthesis, and surface modification of Au nanocages for cancer diagnosis and therapy.
There are a number of ways for analyzing the uptake of Au nanostructures by
cells. One of the most commonly used methods is based on inductively coupled plasma
mass spectrometry (ICP-MS), which can measure the concentration of Au ions down to
the ppb level. This method, however, is rather time consuming as it requires digestion of
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the cells containing Au nanostructures with aqua regia. In contrast, an optical method will
provide many advantages. As reported in literature, Au nanostructures can be excited
optically, resulting in photoluminescence (PL) emission. This phenomenon was first
observed by Mooradian et al. on smooth surfaces of Au, Cu, and their alloys.[1] The
phenomenon arose from a recombination of the photo-excited electrons in the s-p
conduction band with holes in the d-band. The efficiency of the resulting PL was
extremely low, typically on the order of 10-10. In a subsequent study, Boyd et al.
compared the PL from smooth and rough surfaces of noble metals,[2] and it was found
that the quantum yield of the PL was enhanced by several orders of magnitude on a rough
surface due to the local-field enhancement in the proximity to the surface protrusions,
which is analogous to surface-enhanced Raman scattering (SERS). Such enhancement is
more pronounced for noble metals with feature sizes on the nanometer scale, especially
when noble-metal nanoparticles were illuminated by a laser in resonance with the LSPR
peak.[3-8] The PL can also be induced by two-photon excitation and the mechanism is the
same as that induced by single-photon.[2,9] More recently, plasmon-resonant, two-photoninduced PL has been demonstrated with Au nanoparticles and further explored for threedimensional cellular imaging.[10,11] When a Ti:sapphire laser is used, the Au
nanostructures must have the LSPR peak tuned into the NIR region in order to satisfy the
plasmon-resonant condition for strong PL generation. To this end, Wang et. al. has
demonstrated that Au nanorods with a LSPR peak at 820 nm could produce PL signals 58
times that of the fluorescence signal from rhodamine molecules when excited at 830 nm
using a two-photon scheme.[12]
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Similar to Au nanorods, Au nanocages also have LSPR peaks tunable in the NIR
region and are expected to emit strong PL when excited by two-photon excitation under
the plasmon-resonant condition. In this work, I examined the two-photon induced PL of
Au nanocages and their use as an imaging agent for two-photon microscopy. I then use
two-photon microscopy to evaluate the uptake of anti-EGFR-conjugated Au nanocages
by U87MGwtEGFR cells, a cancer cell line that is documented to overexpress epidermal
growth factor receptor (EGFR) on the surface. The results were also correlated with ICPMS analysis of Au content to provide a quantitative understanding of the in vitro and
targeting and uptake processes.

3.2 Two-Photon Photoluminescence of Anti-EGFR Gold Nanocages
I began my studies with Au nanocages that had mean edge length of 50±3 nm and
wall thickness of 5±1.2 nm. The monoclonal antibody, anti-EGFR, was conjugated to the
surface of Au nanocages using a two-step protocol to generate anti-EGFR Au nanocages.
In the first step, orthopyridyl disulfide-poly(ethylene glycol)-succinimidyl valerate
(OPSS-PEG-SVA) was attached to the surface of Au nanocages via the gold-thiolate
chemistry. In the second step, anti-EGFR was coupled to the Au-S-PEG-SVA through an
amide bond. The number of anti-EGFR per nanocage could be controlled by adjusting the
ratio of anti-EGFR to Au nanocages used for the reaction and quantified using the
bicinchoninic acid (BCA) protein assay. Figure 3.1A shows a typical absorbance
spectrum of the Au nanocages with a typical TEM image in the inset showing their
geometry and structure. The LSPR peak of the Au nanocages in an aqueous suspension
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was initially tuned to 770 nm. Surface modification with anti-EGFR red-shifted the LSPR
peak by 10 nm to 780 nm. When the anti-EGFR Au nanocages were transferred into the
culture medium, the LSPR peak was further red-shifted to 795 nm due to a change in
refractive index for the medium surrounding the nanocages. The LSPR peak of the antiEGFR Au nanocages remains symmetric in a Lorentzian shape, indicating that the
nanocages were well-dispersed in the culture medium. Figure 3.1B shows the PL
excitation and emission spectrum from the anti-EGFR Au nanocages as measured using
the two-photon microscope. Similar to PL of Au nanorods,[12,13] the Au nanocages
exhibited a broad PL band extending from 400 to 700 nm when excited by a two-photon
laser with a peak output at 800 nm due to a strong interaction between the localized
surface plasmon and the electric field generated by the laser. In a control experiment, no
PL was observed for an aqueous solution that contained no Au nanocages.

3.3 Receptor-Mediated Endocytosis of Anti-EGFR Gold Nanocages
The PL from Au nanocages provides a simple and convenient way to evaluate
their in vitro targeting capability using two-photon microscopy. In a typical study,
U87MGwtEGFR cells were incubated with anti-EGFR Au nanocages for 3 h at 37 oC in
the presence of FM4-64, a membrane and endosome marker. The PL from the Au
nanocages was recorded in green color (Figure 3.2A) while the fluorescence from the
FM4-64 dye exhibited a red color (Figure 3.2B). Figure 3.2C shows superimposition of
these two images, clearly indicating that the anti-EGFR Au nanocages and FM4-64 dye
molecules were co-localized. This observation implies that the anti-EGFR Au nanocages
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were not only attached to the surface of the tumor cells, but also had been internalized
into the cells. In contrast, tumor cells incubated with the PEGylated Au nanocages under
the same condition showed little PL (Figure 3.2, D-F), suggesting that very few
PEGylated Au nanocages were attached to or internalized into the tumor cells after 3 h
incubation. When the incubation time was extended to 24 h, the PL intensity originating
from the Au nanocages was dramatically enhanced for both anti-EGFR (Figure 3.3A) and
PEGylated Au nanocages (Figure 3.3B). Note that all the images were taken with the
same setting for PL, so their intensities could be directly compared.
I also determined the Au content in the cells by ICP-MS analysis. The
concentration of Au was then converted into the number of nanocages using the
following equations and plotted in Figure 3.3C. For a Au nanocage of L in outer edge
length and l in inner edge length, the number of Au atoms (n) containing in each
nanocage was determined by Eq. 3.1, where a refers to the lattice constant of a unit cell
of Au (a = 4.0786 Å) and there are four Au atoms per unit cell. The number of Au
nanocages (N) can then be calculated by Eq. 3.2, where M refers to the measured number
of Au atoms from ICP-MS analysis.
n=

N=

4( L3 − l 3 )
a3
M
n

(3.1)

(3.2)

At t=3 h, the total number of nanocages uptaken by the cells was 57±10 and 408±40,
while it increased to 190±31 and 826±50, respectively, at t=24 h for PEGylated and antiEGFR Au nanocages. The overall uptake of the anti-EGFR Au nanocages by the cells
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was approximately five times higher than the PEGylated Au nanocages. The
extraordinary uptake of anti-EGFR Au nanocages could be attributed to the endocytosis
mediated by interactions between the anti-EGFR on the surface of nanocage and their
receptors over-expressed on the U87MGwtEGFR cells. The affinity of anti-EGFR to its
antigen is on the order of 0.1-1 nM.[14,15] To further confirm the involvement of receptormediated endocytosis (RME) for the anti-EGFR Au nanocages, I treated the cells with
excess anti-EGFR to saturate the receptors on the cell surface before incubating them
with the anti-EGFR Au nanocages. When the receptors on the cell surface were saturated
by the excess anti-EGFR,[14,15] no PL was observed for the cells after incubation with the
anti-EGFR Au nanocages (Figure 3.3D). However, the FM4-64 dye was still uptaken by
the anti-EGFR pre-treated cells and to give a red color (Figure 3.3E). These results
indicate that the anti-EGFR Au nanocages entered the cells as a result of the interactions
between anti-EGFR and their receptor. The FM4-64 dye molecules were uptaken via a
different internalization pathway that did not work for the Au nanocages. In addition,
temperature may affect the binding rate of the ligands as well as the lateral mobility of
the ligand-receptor complex, resulting in inhibition of the RME process.[16] When the
cells were incubated with anti-EGFR Au nanocages and the dye at 4 oC, neither the
nanocage nor dye was uptaken by the cells (Figure 3.3F).
The RME process involves the binding of antibodies on the nanoparticles to
receptors on the cell surface and internalization of the nanoparticles into the cell when the
cell membrane folds inwards. Eventually, the receptors may be recycled back to the
membrane surface after delivery of the antibody-conjugated nanoparticles into the cell.
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Differentiation of the internalized nanocages from the surface-bound ones could play an
important role in understanding the RME mechanism and thus enhancing the delivery
efficacy of antibody-conjugated nanocages.[17] After incubation with anti-EGFR Au
nanocages, I treated the cells with 20 mM sodium acetate in PBS (pH=3.0) buffer.
Lowing pH is one of the most commonly used treatments for breaking the antigenantibody complexes.[18] In this case, an acidic solution can be used to selectively remove
the anti-EGFR Au nanocages bound to the cell surface.[15] Figure 3.4 shows the
representative confocal images of the cells before and after the treatment of with an
acidic solution. The cells were incubated with anti-EGFR Au nanocages for 1 h at 37 oC
and the excess, free nanocages were removed by washing with PBS three times. As it can
be seen in Figure 3.4, A and B, both the membrane and the interior of each individual cell
were lighted up with green luminescence color due to the presence of Au nanocages.
After the treatment with an acidic solution, the PL from Au nanocages was mainly
located in the interiors of the cells (Figure 3.4, C and D), indicating that most of the
surface-bound nanocages had been selectively removed.

3.4 Time Dependent Study of the Cellular Uptake of Anti-EGFR Gold
Nanocages
I then studied the cellular uptake of anti-EGFR Au nanocages as a function of
incubation time. The U87MGwtEGFR cells were incubated with anti-EGFR nanocages
for different periods of time in the culture medium. After incubation and removal of the
free anti-EGFR nanocages, for each well, the cells were rinsed with an acidic solution
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and the surface-bound nanocages in the washing solution was collected in a conical tube.
The cells were then detached from the culture well with trypsin and collected in another
conical tube. The washing solution and the trypsinized cells were digested in aqua regia
and analyzed for Au concentration by ICP-MS. Figure 3.5 shows plots of surface-bound
number (Ns), internalized number (Ni), and total number (Nt) of nanocages per cell as a
function of incubation time. Note that Ns and Ni were derived from the Au concentration
measured by ICP-MS and Nt is the sum of Ns and Ni. The Ns initially increased, reached a
peak around 1 h, and then fell. The internalization of Au nanocages shows two different
profiles: Ni went up sharply in the first 30 min, and the uptake rate fell off, but still
remained to increase up to 24 h during the course of study. This finding is different from
the previous studies with spherical Au nanoparticles uptaken via clathrin-mediated
endocytosis where the Nt was significantly increased for the first hour, and then the rate
of uptake reached a plateau in 4-7 hours.[19] The discrepancy might be due to the
difference in surface receptor availability, ligand-receptor interaction, the equilibrium
condition between the surrounding and interior of the cell.[20]

3.5

The Number of Antibodies Per Nanocage and its Influence on

Cellular Uptake of Anti-EGFR Gold Nanocages
I also investigated the cellular uptake of Au nanocages with different numbers of
antibodies on the surface of the nanocage. In this case, the Au nanocages were reacted
with anti-EGFR at different molar ratio to yield samples with 16, 28, and 144 anti-EGFR
per nanocage (i.e., anti-EGFR16 Au nanocages, anti-EGFR28 Au nanocages, and anti-
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EGFR144 Au nanocages), respectively. Figure 3.6 shows the PL images of the cells after
incubation with these anti-EGFR Au nanocages for 3 h, and their corresponding
superimpositions with confocal images taken from FM4-64 staining. The co-localization
of the PL from the Au nanocages and the fluorescence from the FM4-64 confirmed that
the nanocages were bound to and internalized into the cells. The PL intensity from the
cells after treatment with nanocages was enhanced as the number of anti-EGFR per
nanocages was increased. This observation was in agreement with the ICP-MS data
shown in Figure 3.7, indicating that the number of Au nanocages per cell increased as the
number of anti-EGFR per nanocage increased.
When a Au nanocage comes into contact with the surface of a cell, only the antiEGFR on one of the six faces could initially interact with the cell surface because of the
cubic shape of the nanocage. In other words, two anti-EGFRs could bind to the cell
surface for anti-EGFR15 Au nanocage, while five anti-EGFRs could interact with the cell
surface for anti-EGFR30 nanocage. Doubling the number of antibodies can improve
multivalent interaction between nanocages and the receptors, resulting in increase in the
number of uptake by 1.5 times. However, when the number of antibodies was increased
by another 5 times to 24 anti-EGFRs on each side face of the nanocage, the number of
internalized nanocages only went up by another 1.3 times. The reduction in uptake could
be attributed to the local depletion of the available receptors as driven by the ligandreceptor binding in the RME process because each anti-EGFR144 nanocage would require
5 and 10 times more receptors as compared to anti-EGFR16 and anti-EGFR44 nanocages,
respectively.[21]
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3.6 Size Dependent Study of the Cellular Uptake of Anti-EGFR Gold
Nanocages
Finally, I compared the internalization of Au nanocages with different sizes. For
receptor-mediated endocytosis, many variables affect the uptake rate of particles,
including driving force of ligand-receptor binding and the receptor mobility on the cell
surface. Gao et. al. developed a model involving a wrapping process for the membrane
and predicted that the optimum diameter in the range of 54-60 nm would be wrapped the
most efficient for spherical particles.[21] From the thermodynamic point of view, Zhang
et. al. also predicted that spherical particles of 50-60 nm in diameter would have a

maximum number of uptake into the cell in the range of 500 to 5000.[20]
I chose Au nanocages with an edge length of 35±4, 50±3, and 90±8 nm (i.e. Au35, Au-50, and Au-90) for this study. All the Au nanocages were conjugated with a
maximum number of anti-EGFR per nanocage. By converting the edge length of cubic
nanocage into its effective diameter (de) with the assumption of equal volume, de equals
44, 62, and 112 nm for Au-35, Au-50, and Au-90 nanocage, respectively. Figure 3.8
shows the number of Au nanocages per cell analyzed by ICP-MS after the cells were
incubated with the Au nanocages with different edge lengths. The number of internalized
Au nanocages was 605±33, 334±30, 170±5, for Au-35, Au-50, and Au-90 nanocages,
respectively. Note that there was a small number for the surface-bound Au-90 nanocages
because the acid solution might not be able to remove the surface-bound nanocages
effectively due to the strong binding between the multiple anti-EGFRs on each nanocage
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to the receptors. The Au-35 nanocages with de of 44 nm were internalized into the cells
with the maximum number. This finding is supported by the theoretical calculation and
previous experimental results that the optimum size for receptor-mediated internalization
is 40-50 nm in diameter for spherical particles.

3.7 Summary
I have evaluated the uptake of anti-EGFR Au nanocages by U87MGwtEGFR
cancer cells using two-photon confocal microscopy. Gold nanocages with LSPR peak
tuned to 780 nm exhibited a broad luminescence band extending from 400 to 700 nm
when excited in a two-photon scheme with a Ti:sapphire laser centered at 800 nm.
Confocal optical images clearly indicate that the anti-EGFR Au nanocages were both
attached to the cell surface and internalized into the cell through receptor-mediated
endocytosis. The qualitative PL results agree well with the quantitative analysis of Au by
ICP-MS. My time-dependent study shows that there was a peaked uptake at 24 h, with a
total of ~800 Au nanocages per cell. The multivalent effect could increase the uptake of
the nanocages although it might compromise the availability of receptors if too many
ligands were present per nanocage. The optimum size of nanocage for internalization is
~35 nm in edge length. The two-photon PL from Au nanocages can be used to quickly
screen their interactions with cells, as well as evaluate their distribution in tissue for ex
vivo and in vivo studies.

3.8 Experimental Section
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Synthesis and characterization of Au nanocages. Gold nanocages with mean

edge lengths of 35, 50, and 90 nm were synthesized through galvanic replacement by
reacting chloroauric acid and Ag nanocubes of 30, 45, and 70 nm in edge length,
respectively. The detailed procedure has been reported in our previous publications.[22,23]
The LSPR peaks of these nanocages were tuned to 770 nm by controlling the amount of
chloroauric acid added into the suspensions of Ag nanocubes. The absorbance spectra
were recorded using a Cary 50 UV-vis spectrophotometer (Varian, Palo Alto, CA). TEM
samples were prepared by dropping an aqueous suspension of the nanocages onto a
carbon-coated copper grid (Ted Pella, Redding, CA) and allowing it to dry under ambient
conditions. The sample was continuously rinsed with water for one hour to remove
residual PVP and then dried before TEM characterization. TEM images were collected
on a Tecnai G2 Spirit Twin microscope (FEI, Hillsboro, OR) operated at 120 kV. The Au
and Ag concentrations of the nanocage suspensions were measured using an Agilent
7500ce ICP-MS (Agilent Technologies, Santa Clara, CA). From the ICP-MS data and
TEM images, the molar concentrations of the nanocages can be calculated. For size
comparison, Au nanocages with mean edge lengths of 35, 50, and 90 nm were prepared
and studied.
Bionconjugation of Au nanocages. Gold nanocages were functionalized with

monoclonal antibodies using a two-step protocol.[24] First, 1 mL of a 1 mM aqueous
solution of OPSS-PEG-SVA (MW≈5000, Laysan Bio, Arab, AL) was mixed with a
suspension of Au nanocages 25 pM in concentration. The suspension of nanocages was
then agitated for 4 h at room temperature in the dark. After incubation, the solution was
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centrifuged at 10,000 rpm for 20 min, and the supernatant was removed. The nanocages
were washed once with PBS. In the second step, 1 mL of PBS containing 10-120 μg of
anti-EGFR (clone LA1, Millipore, Temecula, CA) was added to the nanocages and
incubated at 4 oC for 12 h under agitation. The nanocages were centrifuged and the
supernatant containing free anti-EGFR was kept for BCA assay. The anti-EGFR Au
nanocages were re-dispersed in PBS and stored at 4 oC until future use. For PEGylated
sample, the same amount of Au nanocages was mixed with 1 mL of 1 mM mPEG-SH
(MW≈5000, Nektar Therapeutics, San Carlos, CA). The solution was agitated for 4 h in
the dark at room temperature. Afterwards, the solution was centrifuged, washed once
with PBS, and re-dispersed in 1 mL of PBS. The Au and Ag contents were analyzed
using ICP-MS to determine the final concentration of the functionalized nanocages.
Quantifying the number of anti-EGFR per nanocage. The supernatant collected

previously containing unbound anti-EGFR was analyzed using the BCA assay (Thermo
Scientific, Rockford, IL). This assay uses a bicinchoninic acid formulation for the
colorimetric detection and quantification of protein. The procedures were carried out as
provided by the manufacturer’s instructions. The number of antibodies per nanocage (Na)
was calculated as follows: Na = the total number of antibodies added – the number of
antibodies in the supernatant. Incubation with 10, 35, and 120 μg of anti-EGFR yielded
roughly 16, 28, 144 anti-EGFR per Au nanocage, respectively.
Cell culture. The U87MGwtEGFR cell line was obtained from Prof. Michael J.

Welch in the Department of Radiology at Washington University in St. Louis. The cells
were cultured in the Dulbecco’s modified eagle medium with high glucose (DMEM, HG,
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Gibco, Carlsbad, CA) supplemented with 10% fetal bovine serum (FBS, Gibco) and 500
mg/L of Geneticin (G418, Gibco) under 5% CO2 at 37 oC. The U87MGwtEGFR cells
were reseeded 24 h before experiments in 6-well plate at a population of 5×105 cells per
well. The medium was changed immediately prior to incubation with Au nanocages.
Nanocages (at a final concentration of 0.02 nM) were added into each well and incubated
with gentle rotation for a given amount of time as noted in the text. Dye FM4-64
(Molecular Probe Inc., Eugene, OR), a widely used marker for staining membrane and
endosomes, was incubated with the cells simultaneously at a final concentration of 5
μg/mL. After incubation, the cells were rinsed three times with PBS to remove any

unbound Au nanocages. For the removal of surface-bound nanocages, the cells were
subsequently washed for 10 min at 4 oC with 2 mL of a PBS solution containing 20 mM
sodium acetate with pH adjusted to 3.0 with HCl. They were then rinsed again with the 2
mL PBS solution containing sodium acetate. The washings were collected and saved for
ICP-MS analysis. For blocking experiments, anti-EGFR with a final concentration of 100
nM was added to the cells 1 h prior to the addition of nanocages. For experiments at a
low temperature, the cells were refrigerated at 4 oC for 10 min prior to and then for 1 h
under gentle agitation after the addition of nanocages. The cells were only incubated for 1
h at 4 oC because longer incubation time resulted in cells lifting off from the growth
vessel during the washing process.
Two-photon confocal imaging. After washing off the unbound Au nanocages, the

cells were covered with a coverslip (#1.5, Corning, Corning, NY) and sealed with
vacuum grease. They were kept in the dark and imaged within the next few hours. The
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imaging was performed using an upright Zeiss LSM 510 NLO system (Carl Zeiss)
coupled with a Ti:sapphire laser (Chameleon, Coherent), a green helium-neon (543 nm)
laser, and a 63× water immersion objective (Carl Zeiss). The Ti:sapphire laser was
operated in a mode-locked configuration at a wavelength overlapping with the LSPR
peak of the nanocages, generating sub-200 fs pulse trains at 90 MHz. The PL data were
collected using BP500-550IR. The fluorescence dye was excited at 543 nm, and the
emission was collected with BP650-700IR. Multi-track mode was used to collect both
luminescence and fluorescence images. For comparison, all the confocal images were
taken at the same conditions. The PL emission and excitation spectra of anti-EGFR Au
nanocages in PBS were collected using the same microscope. The suspension of
nanocages was drawn into a microcapillary tube (Vitrocom, 5002-050) for imaging. For
the emission spectrum, the sample was irradiated at 800 nm and the fluorescent images
were simultaneously collected at different wavelengths (380-720 nm, 10 nm intervals).
For the excitation spectrum, the solution was excited at different wavelengths (720-950
nm, 10 nm intervals), and the corresponding fluorescent images, also known as lambda
stack, were simultaneously collected using a BP500-550IR filter. The emission and
excitation spectra were derived from the intensity of the fluorescent signal and from the
collected images using the Zeiss LSM software.
Sample preparation for ICP-MS analysis. For the analysis of surface-bound Au

nanocages, the PBS-acetate washings that were previously collected were digested in 5%
aqua regia. For internalized nanocages, the cells which were washed with the PBS-acetate
solution were removed from the bottom of the well using 2 mL of trypsin, followed by
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two rinses with 1 mL aliquots of media. This solution was collected and then digested in
5% aqua regia. All solutions were centrifuged at 3,000 rpm for 5 min to remove any
cellular debris which may clog the instrument. The Au and Ag contents of the solution
were then analyzed using ICP-MS.
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Figure 3.1 (A) UV-vis-NIR absorbance spectra of the Au nanocages (solid line) in PBS,

anti-EGFR-conjugated Au nanocages (dashed line) in PBS, and anti-EGFR Au nanocages
(dotted line) in the culture medium. The inset shows a TEM image of the corresponding
Au nanocages with a mean edge length of 50 ± 3 nm and wall thickness of 5 ± 1.2 nm.
The scale bar in the inset represents 50 nm. (B) PL excitation (solid line) and emission
spectra (dashed line) of the Au nanocages.
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Figure 3.2 (A-C) Confocal images of the U87MGwtEGFR cells after incubation for 3 h

with 0.02 nM of anti-EGFR Au nanocages and 5 μg/mL of FM4-64 dye: (A)
photoluminescence from Au nanocages; (B) red fluorescence from FM4-64; and (C)
superimposition of (A) and (B). (D-E) Confocal images of the U87MGwtEGFR cells
after incubation with PEGylated Au nanocages and FM4-64 dye for 3 h: (D)
luminescence from Au nanocages; (E) red fluorescence from FM4-64; and (F)
superimposition of (D) and (E). The scale bar applies to all images.
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Figure 3.3 Confocal images of the U87MGwtEGFR cells after they had been incubated

for 24 h with (A) anti-EGFR and (B) PEGylated Au nanocages, respectively. (C)
Quantitative ICP-MS plots showing the number of anti-EGFR and PEGylated Au
nanocages per cell for incubation time of 3 h and 24 h, respectively. (D-F) Confocal
images of the cells that were treated with excess anti-EGFR (100 nM) for 1 h prior to
incubation with anti-EGFR nanocages and FM4-64 for 3 h: (D) photoluminescence from
Au nanocages and (E) superimposition of the luminescence from Au nanocages and red
fluorescence from FM4-64, indicating that the EGF receptors were effectively saturated
and there was essentially no uptake for the nanocages. (F) Superimposition of the
luminescence from Au nanocages, red fluorescence from FM4-6, and phase contrast
image of the cells that were incubated with anti-EGFR nanocages and FM4-64 dye at 4
o

C for 1 h.
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Figure 3.4 Confocal images of the U87MGwtEGFR cells after incubating with anti-

EGFR Au nanocages and FM4-64 for 1 h: (A) luminescence from Au nanocages and (B)
superimposition of the luminescence from Au nanocages and red fluorescence from
FM4-64. Confocal images of the cells incubated with anti-EGFR Au nanocages and
FM4-64 for 1 h, followed by extensive washing with PBS (pH=3.0) containing 20 mM
sodium acetate for the removal of surface-bound nanocages: (C) luminescence from Au
nanocages and (D) superimposition of the luminescence from Au nanocages and red
fluorescence from FM4-64.
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Figure 3.5 Quantitative ICP-MS analysis of the number of anti-EGFR Au nanocages per

cell for samples prepared with different incubation times. The surface-bound Au
nanocages were selectively detached from the cell surface during the treatment with PBS
(pH=3.0) containing 20 mM of sodium acetate.
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Figure 3.6 Confocal images of the U87MGwtEGFR cells incubated for 3 h with 5 μg/mL

of FM4-64 dye and 0.02 nM of Au nanocages having different numbers of anti-EGFR on
the surface. (A-C) Photoluminescence from Au nanocages with roughly (A) 16, (B) 28,
and (C) 144 anti-EGFR on the surface of each nanocage, and (D-F) superimpositions of
the luminescence from Au nanocages and red fluorescence from FM4-64.
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Figure 3.7

Quantitative ICP-MS analysis of the number of surface-bound (■),

internalized (○), and total (▲) anti-EGFR Au nanocages per cell when incubated for 3 h
with 0.02 nM of nanocages having different numbers of anti-EGFR on the surface: 16,
28, and 144. The surface-bound Au nanocages had been selectively detached from the
cell surface by treating with PBS (pH=3.0) containing 20 mM of sodium acetate.
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Figure 3.8 Quantitative ICP-MS analysis of the number of anti-EGFR Au nanocages per

cell when incubated for 3 h with 0.02 nM of nanocages with different mean edge lengths:
35, 50, and 90 nm. The surface-bound Au nanocages had been detached from the cell
surface by treating with PBS (pH=3.0) containing 20 mM of sodium acetate.
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Chapter 4

Quantifying the Photothermal Effect of Antibody-Conjugated
Gold Nanocages Targeted to SK-BR-3 Breast Cancer Cells

4.1 Introduction
The strong optical absorption of some Au nanostructures makes them attractive as
photothermal agents for cancer therapy.[4] Unlike the conventional methods for cancer
treatment (e.g., surgical removal, radiotherapy, and chemotherapy), photothermal
treatment – in which light is converted to heat in vivo to kill cells via hyperthermia –
holds promise as a noninvasive technique for the selective destruction of cancer cells
with minimal injury to the surrounding healthy cells. Several types of Au nanostructures
with strong optical absorption in the near-infrared region have been developed; among
these are Au nanoshells supported on silica cores,[5,6] Au nanorods,[7-9] and Au
nanocages.[10,11] Calculations based upon the DDA method indicate that the nanoshells
tend to scatter light predominately, whereas both the nanorods and nanocages are
stronger light absorbers.[1] Although the ratio of light absorption to scattering may vary
slightly with the dimensions of the nanostructures, these calculations suggest that the
nanocages and nanorods are more effective optical absorbers than nanoshells. The large
absorption cross-section of the Au nanocages was recently confirmed experimentally by
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OCT measurements and found to be approximately five orders of magnitude greater than
that of the conventional organic dyes.[12] Finally, I have found that the absorption peaks
of nanocages can be more conveniently and precisely fine-tuned than those of other Au
nanostructures, potentially allowing for their large scale production for practical
applications.[13,14]
The photothermal effects of the various Au nanostructures were recently
demonstrated, and all were shown qualitatively to be able to destroy targeted cancer cells
upon irradiation with a near-infrared laser.[15-19] However, there are no quantitative
studies of the cellular damage in which parameters such as the number of immobilized
Au nanostructures per cell, the waiting time after irradiation, and the duration of laser
exposure were considered. In this work, I quantify the photothermal effect of anti-EGFR
Au nanocages (i.e., nanocages conjugated with anti-EGFR monoclonal antibodies)
targeted to SK-BR-3 cells – a well-characterized breast cancer cell line that overexpresses
the EGFR – by employing flow cytometry. In doing so, I was able to better elucidate the
interactions between the nanocages, cells, and laser, which will contribute to the
optimization of treatment parameters for future in vivo experiments.

4.2

Preparation and Characterization of the Anti-EGFR Gold

Nanocages
For this study, Au nanocages of 65±7 nm in edge length and 7.5±1 nm in wall
thickness were synthesized through a galvanic replacement reaction using silver
nanocubes (~54 nm in edge length) as the sacrificial template and chloroauric acid,
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HAuCl4, as the precursor to Au.[10-14] Figure 4.1A shows SEM and TEM images of the
Au nanocages. These Au nanocages were shown to contain 37% residual Ag in the form
of an alloy with Au by EDX analysis. If necessary, the residual Ag can be selectively
removed through a dealloying process with the use of Fe(NO3)3 or NH4OH.[20] Using the
DDA method, the absorption, scattering, and extinction spectra were calculated for a Au
nanocage with an edge length of 65 nm, a wall thickness of 7.5 nm, and a pore diameter
of 20 nm at the corners. The results are shown in Figure 4.1B. The Cabs and Csca were
found to be peaked at 6.16x10-14 m2 and 2.02x10-14 m2, respectively, with a Cabs/Csca ratio
of ~3.0. The measured extinction spectrum of the nanocages shown in the inset is
consistent with the calculation. The discrepancy in peak width can be ascribed to the
variations in edge length, wall thickness, the degree of corner truncation, and the porosity
for the Au nanocages contained in a bulk sample.

The Au nanocages were then

conjugated to anti-EGFR antibodies using a two-step procedure which was described in
Chapter 3.[21,22] After conjugation, the extinction peak of these anti-EGFR Au nanocages
slightly red-shifted from 800 nm to 805 nm, which was expected due to the small change
of refractive index on the surface of the nanocages. It is worth pointing out that this
small shift can be taken into account during the preparation of the pristine Au nanocages
to ensure that there will be an exact overlap between the resonance peak of the antiEGFR Au nanocages and the central wavelength of the laser. Recently, Au nanocages
with similar optical properties were demonstrated by us to be effective agents for the in
vitro photothermal destruction of cancer cells.[15] Thus, it was reasoned that these anti-

EGFR Au nanocages would work well for the quantitative studies described here.
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4.3 Quantification of the Targeting Process in vitro
Previously, the targeting selectivity of my bioconjugation protocol was
demonstrated by immunofluorescence imaging and SEM.[21,22] However, no information
with regards to the number of nanocages attached to the cell surface was obtained. This
information is important as it can tell us the amount of nanocages necessary to induce a
photothermal therapeutic effect and allow for better comparisons between my nanocages
and other nanostructures. Thus, in the first part of this study, I sought to quantify the
average number of Au nanocages attached per cell. In addition to Au nanocages, Au
nanospheres of 40 nm in diameter were used as a reference to validate the experimental
procedure due to their well-defined size, shape, and composition.

As a first

approximation, SEM images were taken of the SK-BR-3 cells treated with anti-EGFR Au
nanocages or nanospheres.

The number of nanostructures observed in a randomly

selected 2 μm by 1.5 μm portion of the cell was counted from multiple samples. Based
upon the number of nanostructures measured in that section and the dimensions of the
cell as revealed by SEM imaging, the surface coverage was estimated to be
approximately 200-2000 Au nanostructures per cell. This broad range could be attributed
to the inhomogeneous distribution of receptors on the cell surface.[23] Figures 4.2A and B
show SEM images of individual cells that had been targeted with the anti-EGFR Au
nanospheres and nanocages, respectively. Interestingly, TEM imaging of a microtomed
sample revealed that the Au nanocages were not solely immobilized on the surface of the
cell. As Figure 4.2C shows, some of them were internalized into the cell, although none
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appeared to enter the nucleus. The EGFR antibodies have been reported to trigger
endocytosis, but the exact mechanism for nanocage uptake has yet to be elucidated.[24,25]
While electron microscopy allows us to see where the anti-EGFR Au
nanostructures are located (on the surface vs. inside) and roughly at what coverage, this
technique is of rather limited power when dealing with large numbers of cells. To more
accurately quantify the targeting efficiency of the anti-EGFR Au nanostructures, I
decided to use flow cytometry coupled with ICP-MS. With this approach, the amount of
Au contained in a specific number of cells can be determined. Then from the geometric
parameters of the nanostructures, the number of nanostructures per cell can be calculated.
Specifically, the amount of Au can be easily determined by analyzing the sample with
ICP-MS, while the number of cells in the sample can be easily quantified by spiking it
with a known amount of Sphero Ultra Rainbow beads, followed by flow cytometry
counting. Figure 4.2D shows a typical flow cytometry graph where forward scatter (xaxis) and right angle scatter (y-axis) can be used to differentiate the size difference
between the beads and the cells. Then the number of cells can be quantified using FCS
Express software to gate the populations of both cells and beads. For the standard in
vitro targeting procedure described in the experimental section, I found that there were

approximately 460±130 Au nanospheres per cell and roughly 400±90 Au nanocages per
cell; both numbers fall within the initial estimates from SEM images. In future in vivo
studies, this information should allow for the administration of anti-EGFR Au nanocages
in proper dosages to induce a photothermal effect for tumors of known sizes.
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4.4 Quantification of the Photothermal Treatment Process in vitro
The photothermal treatment with the anti-EGFR Au nanocages was implemented
in vitro with SK-BR-3 cells. The central wavelength of the radiation was 805 nm with a

bandwidth of 54 nm so there was an optimal overlap with the absorption peak of the antiEGFR Au nanocages. Yet, good spectral overlap between the light source and the light
absorbing nanostructure will not alone ensure a good therapeutic effect. Factors such as
time of cellular response to laser irradiation, laser power density, and time of laser
exposure could also influence the efficiency of the photothermal effect.

Thus, I

systematically varied these parameters and quantified the amount of cellular death under
each condition using flow cytometry coupled with propidium iodide (PI) staining.
PI is a popular nuclear or chromosomal counterstain in multicolor fluorescence
techniques and is commonly used in flow cytometry to differentiate cell cycles. When PI
binds to DNA by intercalating between the bases, it fluoresces about 20-30 folds stronger
than unbound PI.[26] Since PI is not permeable to live cells, it works well as a marker to
quantify the number of dying or dead cells in a sample. In addition, it only requires a
short incubation time (<15 min) and can generate well-separated populations of live and
dead/dying cells. In a typical flow cytometry measurement, one can use PI fluorescent
and forward scattering signals to quantify the cellular death caused by the photothermal
effect.
Figure 4.3A shows the experimental setup, where cells in the center of a well
(6.38 mm in diameter; 96-well plate) were irradiated with the Ti:Sapphire laser with a
spot size of 2 mm. The SK-BR-3 cells are adherent, hence their position is fixed on the
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surface of the well. It should be pointed out that the laser only irradiated 9.8% of the
cells in each well (note cells are not drawn to the scale). I also tried to use smaller wells
(e.g., 3.7 mm in diameter; 384-well plate), but were found to increase the experimental
error so the 96-well plate was used. In one study, the treated cells were harvested at
various times after irradiation to investigate when cells start to respond to the
photothermal treatment. In Figure 4.3B, the cells were irradiated at a laser power density
of 4.77 W/cm2 for 5 min. After that, the cells were returned to a 37 oC incubator for a
specific duration of time before the percentage of cellular damage was quantified. Cells
targeted with the anti-EGFR Au nanocages (in black) exhibited more cellular damage at
early harvest times. The cellular damage decreased at harvest times greater than 3 h after
laser exposure, which could possibly be attributed to: i) the cells untouched by the laser
proliferated during their course in the incubator, resulting in a dilution of the destructed
cells, and/or ii) some of the damaged cells recovered from the photothermal effect. Cells
irradiated under the same conditions but without the anti-EGFR Au nanocages (in red)
exhibited no significant response during the given time. A small, unavoidable percentage
of cellular death was observed, probably due to the pipetting and handling of cells during
sample preparation. The results of this study indicate that the cells respond immediately
to the photothermal treatment and should be harvested within 3 h after irradiation to
better reflect the treatment. Harvest times shorter than 1 h after laser irradiation are not
feasible due to the time required to prepare the sample for flow cytometry.
Figures 4.3C and D show the flow cytometry graphs of the cells with and without
targeting by the anti-EGFR Au nanocages, respectively, at a harvest time of 3 h after
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laser irradiation. Forward scatter is plotted on the x-axis and PI emission signal is plotted
on the y-axis. The flow cytometry graphs were sectioned into four quadrants. QuadrantI, exhibiting a large forward scattering and low PI signal, represents the population of live
cells. Since the live cells have intact cell membranes, PI could not stain their DNAs.
Quadrant-II, displaying large forward scattering and high PI signal, corresponds to the
population of dying cells. The membranes of these cells had been compromised so PI
could penetrate and then hybridize with their DNAs. The population of dead cells, or
stained DNAs, exhibits a high PI and small forward scattering signal as shown in
quadrant-III. These are free DNAs, no longer enclosed within a membrane. Quadrant-IV
reveals a population with small forward scattering and low PI signal that could be
attributed to instrumental background signals and debris from ruptured cells.

The

population in quadrant-IV does not representatively correspond to live or damaged cells,
so the percentage of cellular damage was normalized to the population in quadrants I, II
and III. A higher population of damage was observed when the cells were targeted with
the anti-EGFR Au nanocages. These results exemplify that the anti-EGFR Au nanocages
are effective photothermal agents capable of absorbing light and converting it into heat.
The flow cytometry data also reveals that cells targeted by the anti-EGFR Au nanocages
display irreversible damage upon photothermal treatment, as shown by the larger
population in quadrant-III, where the cellular membrane is broken to such an extent that
the cell can no longer function nor recover from the damage. Although a small portion of
damaged cells are present in quadrant-II, the majority is observed in quadrant-III
suggesting that the decrease of cellular damage over time was cause by the proliferation
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of cells outside the spot size and not by the recovery of the compromised cells as
speculated earlier.
I also investigated the effect of the laser power density. Figure 4.4 shows a plot
of cellular damage against the laser power density for cells irradiated for 5 min and
harvested 3 h after irradiation. In the control, the cells without Au nanocages (in red)
maintained viability and the values are consistent with the control experiments shown in
Figure 4.3. Cells treated with the anti-EGFR Au nanocages (in black) exhibited little or
no damage at power densities less than 1.6 W/cm2. At some threshold between 1.6 and
2.4 W/cm2, the damage becomes significantly greater than the control.

At power

densities greater than 1.6 W/cm2, the damage for cells treated with the anti-EGFR Au
nanocages increases linearly, similar to what was found in previous publication.[15] As
the power density increased to 6.4 W/cm2, the cellular damage increased to 55%. Since
the laser irradiated only 9.8% of the well, the cellular damage extended beyond the spot
size of the laser, as is expected because the amount of heat generated increases with
increasing laser power. As will be discussed later, the heat generated within the spot size
can transfer to surrounding regions.

Depending on the stage and type of cancer,

cancerous cells can invade local regions of tumor sites and removal of nearby regions
may be necessary, thus this linear relationship provides a means of calibrating the
treatment to kill cancerous cells that have broken away from the primary tumor.
Alternatively, by keeping the power density low, collateral damage to nearby healthy
cells can be minimized.
The cells were also exposed to the laser for different periods of time. Figure 4.5
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shows a plot of cellular damage against the duration of laser exposure for cells irradiated
at 4.77 W/cm2 and harvested 3 h after irradiation. In the control, cells without anti-EGFR
Au nanocage treatment (in red) maintained viability, which is consistent with the results
from the control experiments shown in Figures 4.3 and 4.4. The percentage of damage
for cells treated with anti-EGFR Au nanocages (in black) continuously increased for the
first 5 min. After 5 min, the cellular death reached a steady percentage at about 35%. An
exposure time of 1 min resulted in cellular damage (18%) larger than the percentage of
cells irradiated by the laser (9.8%), suggesting that Au nanocages in the spot size of the
laser irradiation responded quickly to the exposure. As the exposure time increased to 5
min, the cellular death increased signifying that the death outside the spot size of the laser
depends on the amount of time necessary for heat generated from the anti-EGFR Au
nanocages to transfer to cells outside the irradiated regions. The cellular death becomes
steady after 5 min, which could be attributed to other temperature gradients in the
surroundings thus establishing equilibrium. This relationship is important for calibrating
the laser parameters for practical applications of in vivo photothermal treatment. For
example, a high-powered laser can be expensive, so rather than increasing the power of
the laser, the time of laser exposure could be easily prolonged; however, after some
extended period of time, the cellular death will become steady. This parameter provides
another approach to treat the local invasion of tumor.

4.5 Summary
I have quantified the targeting and photothermal therapeutic effects of 65-nm anti-
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EGFR Au nanocages on SK-BR-3 breast cancer cells. Additionally, by combining PI
fluorescent labeling with flow cytometry, I was able to distinguish between live and dead
cells. This technique proved to be extremely powerful at determining and quantifying the
number of nanocages per cell. The relationship between laser parameters (i.e. power
density and duration of laser exposure) and cellular damage was also better elucidated.
The information garnered from this work will aid in future in vivo studies in which the
dosage of anti-EGFR Au nanocages and the power density and exposure time of the laser
can be optimized to treat individual conditions (e.g., tumor size and local invasion of
tumor).

Additionally, this study provided more information about the interaction

between the cells, anti-EGFR Au nanocages, and laser. For example, it was previously
unknown that the anti-EGFR Au nanocages were internalized by the cells.

My

photothermal studies also showed that cells targeted with anti-EGFR Au nanocages
respond immediately to the laser stimuli, and that the amount of cellular death can be
controlled by both the exposure time and power density of the laser. Cells treated under
the same experimental conditions but without anti-EGFR Au nanocages maintained their
viability. The efficacy for the anti-EGFR Au nanocages to kill cancer cells can be
attributed to their selective targeting and large absorption cross-section of near-infrared
light. The results reported here provide insight into how the photothermal response of
anti-EGFR Au nanocages can be optimized and controlled. This knowledge is critical to
providing effective, noninvasive treatment of cancer in vivo via photothermal therapy.
Future work will also address the stability of Au nanocages in conjunction with its
biodistribution via local and systemic administration as well as collateral damage to
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nearby healthy cells.

4.6 Experimental Section
Preparation of anti-EGFR Au nanocages. Au nanocages were prepared using

the galvanic replacement reaction between HAuCl4 and Ag nanocubes as the template.
The detailed procedure was described in Chapter 2. SK-BR-3 and U87MGwtEGFR cells
both overexpress EGFR on their surface, so the same two-step protocol in Chapter 3 was
employed here to target SK-BR-3 cells.

For these experiments, the amount and

concentration of Au nanocages needed are 1 mL of a 2 nM solution. The thiolated
poly(ethylene glycol) (PEG) was OPSS-PEG-SC (Laysan Bio, MW≈5,000) and the
amount and concentration used was 1 mL of a 1 mM solution.
Cell culture. The breast cancer cell line SK-BR-3 (ATCC, HTB-30) was cultured

in McCoy’s 5a Medium Modified (ATCC, 30-2007) containing 10% Fetal Bovine Serum
(FBS, Invitrogen, 16000) and 5% streptomycin/penicillin (Invitrogen, 15140) at 37 oC in
5% CO2 (v/v). The medium was changed 2-3 times a week. When they reached a
confluency of 60-90%, the adherent cells were removed from the growth vessel with
trypsin (Gibco, 25200). The trypsin was deactivated by adding the growth medium. The
suspension of cells was centrifuged for 5 min at 1,000 rpm, and the pellet of cells were
resuspended in growth medium and then transferred to a desired growth vessel (flask,
multi-well plate, or petri dish) for quantitative and photothermal studies.
Preparation and imaging of SEM samples. The SK-BR-3 cells were transferred

to a silicon wafer and allowed to settle overnight in a 12-well plate. The SK-BR-3 cells
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were fixed with methanol, and then washed three times with tris-buffered saline tween-20
(TBST), followed by a rinse with tris-buffered saline (TBS). The cells were incubated
with 20 μL of the anti-EGFR Au nanocages in TBS for at least 3 h, with 1 h of gentle
agitation. After that, the cells were washed three times with TBST and one time with
TBS. The sample was briefly rinsed with water and dried before SEM characterization
using a Sirion XL field-emission microscope (FEI, Hillsboro, OR) operated at 5 kV.
Preparation and imaging of microtomed samples. The SK-BR-3 cells were

grown in a 35-mm Petri dish. They were then incubated with 50 μL of the anti-EGFR Au
nanocages in medium for 3 h, with 1 h of gentle agitation. Then, the cells were rinsed
three times with PBS and fixed with a solution containing glutaraldehyde (2.5%),
cacodylate (0.1 M), sucrase (0.1 M), CaCl2 (0.4 mM) overnight at 4 oC. The cells were
post-fixed with OsO4 (1 %) in cacodylate (0.1 M) and CaCl2 (0.4 mM) for 2 h at room
temperature, followed by uranyl acetate (2 %) in water for 1 h at room temperature. The
cells were dehydrated through a graded ethanol series, and finally embedded in eponate
(Ted Pella, Redding, CA) epoxy resin and set aside to polymerize for 48 h at 60-65 oC. A
microtome (Reichert/Jung Ultra-cut E, Leica, Arcadia, CA) equipped with a diamond
knife was used to cut the cured epoxy resin into slices with a thickness of 80-100 nm.
The cell slices were contrasted with an aqueous solution of uranyl acetate (7 %) and lead
citrate.[27] The samples were examined using a JEOL EXIII TEM.
Quantification of the number of Au nanostructures attached per cell. SK-BR-3

cells were grown in a 12-well plate and incubated with 20 μL of the anti-EGFR Au
nanospheres (Ted Pella, 40 nm in diameter) or 20 μL of the anti-EGFR Au nanocages for
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3 h (with 1 h of gentle agitation) in a solution that contained the growth medium. They
were rinsed three times with PBS. The adherent cells were removed from the growth
vessel with trypsin as described previously. The suspension of cells was collected and
spiked with a known amount of Sphero Ultra Rainbow beads (Spherotech, URFP-100-2,
10.2 μm).

A known amount of the sample was then inserted into an influx flow

cytometer (Cytopeia) with a 488 nm argon laser as the excitation source. Data analysis
was performed using FCS Express (DeNovo) software to determine the number of cells
in the solution. The remainder of the sample was analyzed to determine the amount of
Au present in the sample using ICP-MS (PerkinElmer Elan DRC-e).
Photothermal treatment. SK-BR-3 cells in 96-well plates were incubated with 12

μL of the anti-EGFR Au nanocages for 3 h (with 1 h of gentle agitation). The cells in the

center of the wells were irradiated with a Ti:Sapphire laser with a central wavelength at
805-nm and a bandwidth of 54 nm. The near-infrared light source was a femtosecond
pulsed irradiation generated from a home-built Kerr-lens mode-locked Ti:Sapphire laser
with 82 MHz repetition rate. The Gaussian beam size was adjusted with a convex lens (B
coating, BK7, f = 75 mm) and the sample was positioned at a distance such that the spot
size was 2 mm in diameter. An iris diaphragm was used to block light outside the spot.
The laser power density was adjusted using a neutral attenuator.

The duration of

irradiation and the power density for photothermal treatment are described in the text.
After laser irradiation, the cells were incubated in the medium at 37 oC until they were
harvested and analyzed.
Quantification of the photothermal effect. After a certain period of incubation
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(as indicated in the text), the cells were rinsed with PBS and then harvested with trypsin
as described previously. The suspension of cells and rinses with PBS were collected in a
tube for flow cytometry analysis. The cellular suspension (400 μL) was treated with PI
(12 μL, Molecular Probes, 1 μg/mL stock, in dH2O) and then inserted into the flow
cytometer. The PI fluorescent signal was collected using a 625/25 BP filter. The data
was analyzed using the FCS Express software.
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Figure 4.1 (A) SEM and TEM (inset) images of Au nanocages synthesized using the

galvanic replacement reaction in which Ag nanocubes serve as a sacrificial template. The
scale bar in the inset represents 100 nm. (B) The absorption (Cabs), scattering (Csca), and
extinction (Cext) cross-sections (note that Cext = Cabs + Csca) as a function of wavelength
were calculated using the DDA method for a Au nanocage with the following
geometrical parameters: edge length = 65 nm, wall thickness = 7.5 nm, and corner holes
with diameter = 20 nm. Also for the DDA calculations, the nanocages were assumed to
be in water and have a composition of 37 % Ag and 63 % Au. The inset shows the UVvisible absorbance spectrum for the nanocages shown in (A), which have a resonance
peak at 800 nm, in agreement with the calculations.

101

Figure 4.2 SEM images of SK-BR-3 cells targeted with anti-EGFR Au nanospheres (A)

and nanocages (B). SEM images at higher magnification (insets) reveal that the bright
spots in the SEM images are indeed nanospheres and nanocages, respectively. The scale
bar in the insets represents 500 nm. (C) A TEM image of a microtomed SK-BR-3 cell
conjugated with anti-EGFR Au nanocages. In addition to anti-EGFR Au nanocages
decorating the surface of the cell, this microtomed TEM image reveals that some antiEGFR Au nanocages are internalized by the cell. However, they do not appear to enter
the nucleus. (D) A typical flow cytometry graph indicating how the forward scatter (xaxis) and right angle scatter (y-axis) can be used to differentiate the size difference
between beads and cells. As the concentration of beads is known for a given sample, it
provides an internal reference for measuring the concentration of cells; when this data is
coupled with ICP-MS analysis for Au, the number of anti-EGFR Au nanocages per cell
can be estimated.
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Figure 4.3 (A) An illustration depicting the experimental setup used for photothermal

therapy of SK-BR-3 cells. The cellular growth vessel had a diameter of 6.38 mm. The
cells were irradiated with an 805-nm Ti-Sa laser with a spot size of 2 mm. Thus, only 9.8
% of the cells in the well were exposed to the laser. Note: cells not drawn to scale. (B)
Plots of the percentage of cellular damage versus harvest time when SK-BR-3 cells were
irradiated for 5 min at a laser power of 4.77 W/cm2. The solid dots show the results for
cells targeted with anti-EGFR Au nanocages, and the open dots show the control (no
incubation with anti-EGFR Au nanocages). (C) The flow cytometry graph analyzed to
determine the percentage of cellular death after SK-BR-3 cells were incubated with antiEGFR Au nanocages, irradiated for 5 min at a power density of 4.77 W/cm2, then
harvested at 3 h for analysis. (D) The flow cytometry graph obtained from the control
experiment in which SK-BR-3 cells were not treated with anti-EGFR Au nanocages but
treated to similar laser treatment. For both (C) and (D), the signal in quadrant III
corresponds to population of dead cells.
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Figure 4.4

Plot of cellular damage versus laser power density for SK-BR-3 cells

incubated with anti-EGFR Au nanocages (solid dots) and for the control in which cells
were not incubated with anti-EGFR Au nanocages (open dots). Cells were irradiated for
5 min and then harvested for analysis 3 h after irradiation.
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Figure 4.5

Plot of cellular damage versus laser exposure time for SK-BR-3 cells

incubated with anti-EGFR Au nanocages (solid dots) and for the control in which cells
were not incubated with anti-EGFR Au nanocages (open dots). In both cases, the cells
were irradiated with a 805 nm laser at a power density of 4.77 W/cm2 then then harvested
for analysis 3 h after irradiation.
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Chapter 5

Synthesis of Gold Microplates Using Bovine Serum Albumin as
a Reductant and a Stabilizer

5.1 Introduction
Anisotropic 2-D structures have been recently gained attention because of their
unique optical properties and potential use in chemical and biological sensing.
Triangular and hexagonal plates are of interest because they have particularly attractive
optical properties. They exhibit both dipole and quadrupole plasmon resonance peaks
due to their anisotropic shape. It has been demonstrated that as Au nanoplates grow
larger into microplates, their dipole resonance shifts into the near-infrared region and
their quadrupole resonance peak becomes more prominent.[1,2] Their resonance peaks in
the near-infrared region are useful for biological applications because soft tissues are
transparent in this range. Moreover, their sharp corners and edges also make them useful
as substrates for surface-enhanced Raman scattering (SERS).[3] Researchers have long
studied the synthesis of plates and their mechanism of formation using electron
microscopy and theoretical modeling.[4-7] The major conclusions reached thus far are the
following: plates are derived from seeds with planar defects (e.g., lamellar twins or
stacking faults).

These planar defects can be obtained from kinetically controlled
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syntheses, in which the reduction of a salt precursor is relatively slow and the atoms will
rearrange in a randomly hexagonal closed-packed (rhcp) structure—a mixture of both
hexagonal close-packed (hcp) and cubic close-packed (ccp) stacking. Nuclei with an
rhcp structure can easily evolve into a plate-like seed which are characterized by vertical
stacking faults. Nanoplates have been synthesized in various ways through thermal and
photochemical methods.[8,9]

Recently, there has been a number of green chemistry

methods developed to produce Au plates using biological molecules.
Biological systems assemble inorganic nanoscale building blocks into structures
with controlled size and complex patterning, such as bones and shells. Researchers have
long tried to understand this process, and more recently, to harness it to grow
nanostructures with controlled morphologies. For gold, previous biological syntheses
have employed extracts from lemongrass,[10] brown seaweed,[11] unicellular green alga[12]
and filamentous fungus[13] to grow nanoplates. These extracts are inherently mixtures of
proteins, so it is difficult to identify the particular protein structure responsible for
guiding the growth of nanoplates.
Serum albumin is the most abundant plasma protein in mammals and is essential
for the regulation of the colloidal osmotic pressure and maintenance of pH levels in
blood.[14]

It is the principal transporter for a variety of substances with different

properties (e.g., hydrophobic or hydrophilic, anionic or cationic). Bovine serum albumin
(BSA) is one of the most thoroughly characterized, inexpensive and ubiquitous proteins.
BSA has a molecular weight of ~66 kDa and is composed of 582 amino acids, of those,
35 are threonine and 32 are serine units.[15-18] These amino acids bearing hydroxyl
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groups can serve as reducing agents. For example, poly(vinyl pyrrolidone) containing
two hydroxyl end groups has been shown to be a mild reducing agent capable of
producing nanoplates of noble metals such as Au, Ag, Pt, Pd.[19]
Previously, BSA has been shown to be a good stabilizer for the synthesis of AuAg and Ag-Pt alloy nanoparticles owing to their excellent foaming behavior and ability to
simultaneously bind to both Ag+ and AuCl4- or PtCl6-, respectively, ions due to its
zwitterionic characteristic at the isoelectric point (BSA pI = 4.7).[20,21] I found that BSA
not only acts as a stabilizing agent against the aggregation of Au nanoparticles, but also,
the hydroxyl groups of BSA make it a reducing agent, so no additional reductant is
required. In this study, I focus on the effect of BSA on the growth of triangular and
hexagonal Au microplates in an aqueous buffered solution.

The conformation of the

protein is an important factor for the synthesis of these Au microplates and is dependent
on temperature and pH of the reaction. Additionally, the ions in the environment are
important to the stability of the protein structure.

5.2 Unfolding the Structure of BSA
In its native state, BSA is a heart-shaped protein and consists of three homologous
domains (I, II, and III), each bearing a number of ionizable groups.[22,23] The secondary
structure of BSA consists of 67% helix, 10% turn, and 23% extended chain.[24] The
cysteine residues are responsible for the tertiary structure of the protein. They form 17
disulfide bonds which results in nine loops. It is worth pointing out that BSA has one
free sulfhydryl group located at the cysteine residue in position 34 of the amino acid
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sequence (Cys-34). Cys-34 is located in a crevice near the surface of the protein and is
thereby protected by neighboring residues. Figure 5.1A shows an illustration of a portion
of BSA. When the protein is exposed to heat and HAuCl4, the structure of BSA can
unfold to reveal the reductive hydroxyl groups in threonine and serine units.
Customarily, disulfide bonds in protein are reduced with mercaptans such as thioglycolic
acid, 2-mercaptoethanol, and cysteine.[25] However, in the presence of gold, the disulfide
bond will break and form a Au-thiolate bond. It has been previously observed that
HAuCl4 in the presence of a thiol can from a Au-chloride-sulfur complex.[26] Recently, it
was reported the cys-34 residue of BSA and thiomalate (Stm) can coordinate to form
albumin-S-Au-Stm.[27] Hence, it is possible that such an intermediate complex could be
formed in my system, which will facilitate in breaking the disulfide bonds in BSA and
further promote the unfolding of the protein and expose more hydroxyl groups. Both
hydroxyl and sulfhydryl groups are important for the synthesis of Au microplates: the
hydroxyl group serves as the reducing agent and the sulfhydryl group provides the BSA
molecule a chemical method of attaching to the Au surface to function as a stabilizing
agent.
The scanning electron microscopy (SEM) image in Figure 5.1B shows the
microplates obtained at the experimentally determined optimal conditions. In this case,
0.050 g of BSA was dissolved in 5 mL of tris-buffered saline (TBS, pH = 7.4) and heated
at 55 oC for 30 minutes before the addition of 3 mL of 18.8 mM HAuCl4 in TBS.
Throughout this chapter, this protocol will be referred to as the standard procedure or
method. The initial BSA solution was clear and colorless. Upon the addition of HAuCl4,
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the solution became cloudy and yellow. This yellow color was due to the presence of
Au3+ ions and the turbidity was due the denaturation of BSA. Within 10 minutes, the
yellow color disappeared, leaving behind a white opaque solution. The loss of the yellow
color indicated the reduction of Au3+ to Au1+. The cloudy solution then developed a light
reddish-brown color, indicating the presence of nanoparticles. As the reaction continued,
the Au particles grew to form micron-sized plates and the solution evolved to a clear,
shimmery yellow solution after 2 hours. The pH of the solution was measured after the
addition of HAuCl4 and found to have dropped from 7.4 to 2.0.

The majority of the

products were hexagonal and triangular plates with mean edge lengths of 3.6 ± 0.6 μm
and 8.6 ± 2.0 μm, respectively.

Figure 5.1C and D show TEM images of single

hexagonal and triangular plates, respectively. Their corresponding electron diffraction
(ED) pattern (insets of Figure 5.1, C and D) was taken by directing the electron beam
perpendicular to the flat faces.

Three sets of patterns can be seen.

The squared,

triangled, and circled spots can be indexed to the {220}, {422}, and forbidden 1/3{422}
reflections, respectively. Such diffraction spots are consistent with previous observations
of Au and Ag plate structures.[2,19,28]

The observation of the forbidden 1/3{422}

reflection reveals the presence of (111) stacking faults. This twinned defect disrupts the
fcc symmetry of gold and is responsible for the formation of anisotropic disc structures.

It should be noted out that planar defects can be produced by the slow reduction derived
from the mild reducing power of BSA.

5.3 Effect of Temperature
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Temperature plays an important role in this synthesis. As previously discussed, it
is expected to influence the conformation of the protein. The driving force for protein
denaturation is entropy, and an increase in the temperature would increase the entropic
effect. Moreover, the temperature should affect the reduction rate of Au ions as well as
the rates of the nucleation and growth processes of the nanocrystals. I explored various
temperatures ranging from 4 oC to 75 oC, while keeping the rest of the parameters the
same as the standard procedure. I found that at 4 oC, BSA had very little reduction
capability. The reaction remained yellow and cloudy for up to one week. A TEM image
of this sample at 40 hours revealed that 1-10 nm seeds were embedded within the protein
as shown in Figure 5.2A. This result means that BSA protein had some reductive
capability at 4 oC, though the reduction of Au ions was exceedingly slow and the growth
of these seeds into larger crystals was not observed. Subsequently, I increased the
temperature of the reaction to physiological temperature, 37 oC.

The reaction was

completed within 18 hours and exhibited the same color progression as the standard
method over this time period. Few hydroxyl groups are expected to be exposed at 37 oC
since BSA only begins to denature at 40 oC, and as a result, the reduction was very slow.
I also conducted the synthesis at 45 oC and found that the reaction rate increased
considerably; the reaction was completed within 4 hours.

However, the products

obtained at 37 oC and 45 oC were polydispersed samples containing both particles and a
broad size distribution for the plates. Figure 5.2B shows the SEM image of the products
obtained at 37 oC. This polydispersity was likely due to the different conformations of
the BSA present during heating. During the initial stages of heating, unlocking the
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tertiary structure removed a number of bonds holding the structure together, thus
increasing the number of possible BSA configurations. The hydrogen bonds within the
alpha helices were broken and the structure unfolded to random coils, which can align
and hydrogen bond between each other to form β-sheets. It is worth pointing out that the
conformation of the protein was reversible for temperatures less than 52 oC, resulting in
small fluctuations between the structures of BSA molecules which may be responsible
the polydispersed sample.
It was not until the reaction was increased to 55 oC when I obtained a good
distribution of Au plates (Figure 5.1B).

The unfolding of the α-helices of BSA

molecules was irreversible at temperatures higher than 52 oC because the cysteine pocket
unfolded and formed disulphide bonds between the β-sheets. [24,29-31] Thus, I expect the
structure of the protein to be quite stable at 55 oC, which will aid in the formation of
uniform plates. Figure 5.2C shows hexagonal and triangular plates that were obtained at
a reaction temperature of 65 oC. The plates have a similar size distribution to those
obtained in the standard procedure. It seems that within this temperature range, 55 oC 65 oC, the structure of the BSA was relatively stable and formed uniform plates.
However, at temperatures above 70 oC the α-helices continue to unfold and form βaggregation. As the temperature of the reaction was increased to 75 oC, the color of the
reaction progressed differently. It evolved from yellow and turbid, to cloudy white, and
then finally opaque dark reddish-brown. The SEM image in Figure 5.2D shows that the
product obtained at 75 oC consisted of a mixture of spherical particles and plates. The
inset in Figure 5.2D shows a SEM image at a higher magnification for the spherical
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particles revealing that they were actually decahedrons and icosahedrons. These twinned
particles are typically observed from seeds with metastable rhcp structure.[5]

The

hexagonal and triangular plates have mean edge lengths of 1.5 ± 0.7 and 3.0 ± 2.5 nm,
respectively. The sizes of the hexagonal and triangular plates synthesized at 75 oC were
significantly smaller than those that were synthesized at 55 oC.
This dramatic difference is likely attributable to the conformation of the protein
rather than the faster reduction of Au ions at higher temperatures.

To prove this

hypothesis, I conducted a reaction where the BSA solution was heated to 75 oC for 30
minutes, and then lowered to 55 oC. The shape of the protein should not change when the
temperature was lowered since the conformation is irreversible when heated above 52 oC.
HAuCl4 was added to the solution and the reaction was completed in 2 hours. The SEM
image in Figure 5.3 reveals that the products were a mixture of plates and particles,
similar to what was obtained when the reaction was held at a constant temperature of 75
o

C. The hexagonal and triangular plates have mean edge lengths of 1.2 ± 0.5 μm and 2.3

± 2.1 μm, respectively, which were not significantly different from the products obtained
at the constant 75 oC. Though the temperature had some influence on the reaction
kinetics, it was the conformation of the BSA that strongly affected the synthesis at this
temperature range.

5.4 Effect of pH
As mentioned earlier, the pH value is also expected to affect the structure of the
protein. BSA contains a large number of groups that can be protonated at different pH
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conditions, which can alter the hydrogen bonding within BSA molecules (i.e. α-helices)
and lead to variation in the structure of the protein.[32] BSA has five pH-dependent
structural transitions, all of them are reversible.[33] These states and their points of
transition are summarized in Table 1 (modified from ref. [32]).

In my previous

syntheses, the BSA was preheated for 30 minutes in TBS solution with a pH value of 7.4.
At this pH value, the BSA was in its native, globular state also known as the normal
dominant (N) form. When HAuCl4 was added to the solution, the pH value decreased to
2.0 and the protein underwent two structural changes: the fast migration (F) and
expanded (E) forms. The N-F transition implies the opening of the protein by unfolding
domain III, resulting in a loss of α-helix content.[34] The macromolecule further unfolds
and loses the helical structure connecting domain I with domain II and III in F-E
transition.[35]
In this section, I examined the effect of pH by changing the initial pH value of
TBS solution from ~9 to 3.0 or 10.0 through the addition of HCl and NaOH, respectively.
The reaction was carried out the same manner as the standard method, except the TBS
solution utilized in the reaction had a pH value of 3.0 or 10.0. When the reaction was
conducted with TBS of pH = 3.0, the color of the reaction progressed similar to the
standard procedure. The final solution was a clear, shimmery yellow solution. Figure
5.4A shows the Au microplates obtained at when TBS with pH = 3.0 was utilized. The
pH of the solution was measured at the end of the reaction and found to have decreased to
1.7, similar to the pH value of 2.0 that was measured for the standard method. The
structure of the protein at the end of the reaction is expected to be the same structure as in

117

the standard method, which is the E form. The mean edge lengths of hexagonal and
triangular plates were 5.8 ± 1.6 and 15.8 ± 3.9 nm, respectively. These plates were
significantly larger than the plates obtained in the standard procedure. It was previously
observed that in acidic conditions, Au plates grew larger than those synthesized in less
acidic environment.[36]

I propose that the presence of additional H+ ions provides

increased stability for the Au ions by forming a Au ion complex and hence slowing down
the reduction of Au. As a result, the number of seeds formed was reduced and more
atoms can be adsorbed to the seeds, which allowed for the formation of larger crystals.
For the reaction conducted with TBS at pH = 10.0, the reaction progressed in
different manner. Upon the injection of HAuCl4, the reaction was a clear yellow solution
instead of the previously cloudy solution. The solution started turning cloudy after one
hour and remained light yellow and cloudy for the next day and a half. Around 40 hours
into the reaction, the solution turned light purple, indicating the formation of
nanoparticles. When the reaction was carried out for longer times, the solution turned
into a dark purple color. Figure 5.4B shows the product obtained at 40 hours are indeed a
mixture of nanoparticles. While most of the products were spherical nanoparticles with
mean diameter of 8.6 ± 1.0 nm, triangular nanoplates with a mean edge length of 12.2 ±
3.5 nm were produced. The pH of the solution was measured and found to have dropped
from 10.0 to 5.6, which means that the structure of the BSA was in the N form at the end
of the reaction. By varying the pH of the reaction, I have found that microplates tended
to form in acidic conditions when the protein was in the E form, whereas small
nanoparticles formed in neutral conditions when the protein was in the N form.
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It was previously reported that BSA has one sulfhydryl group available at pH = 7
and three sulfhydryl groups exposed at pH = 3 in the presence of thioglycolic acid.[37] At
these pH values, the shape of the BSA corresponds to the N and E forms, respectively. I
suspected that in addition to the shape of the protein, the number of sulfhydryl groups
available was responsible for the different Au structures synthesized. I observed that the
N form produced many small spherical nanoparticles, whereas the E form produced the
larger triangular and hexagonal plates. The N form of the protein is globular with one
sulfhydryl group exposed, which means that many BSA molecules can surround and
stabilize the small nanoparticle. On the other hand, the E form of BSA is an elongated,
linear structure and has multiple sulfhydryl groups which can attach to various points on
the surface of a flat Au structure. This linear conformation of BSA promotes the growth
of plates by attaching to its flat surface, thereby allowing atoms to add on to the edges.

5.5 Effect of BSA Concentration
Figure 5.5 shows the SEM images of the products synthesized with different
amounts of BSA while keeping the rest of the parameters the same as the standard
method. Generally as the amount of BSA increased from 0.010 to 0.090 g, the edge
length of hexagonal plates decreased from 4.6 µm ± 1.9 µm to 1.8 µm ± 0.2 µm. This
trend has been observed in many other systems and can be attributed to the following
logic: the increase of reductant resulted in the formation of more nuclei. Consequently,
less salt precursor was available per nuclei so crystals could not grow to larger sizes.[38]
Considering BSA as a stabilizing agent, an increased concentration of stabilizing agent
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would more effectively form a stabilizing layer around each plate thus preventing the
growth of larger plates.

Previous syntheses using poly(vinyl pyrrolidone) as the

stabilizing agent for the platinum oxide nanoparticles have also demonstrated this
behavior.[39] There was no color change to indicate reduction for reactions with less than
0.010 g of BSA. Reactions containing more than 0.15 g of BSA resulted in the formation
of gels.

5.6 AFM Characterization of Gold Microplates
The Au microplates synthesized using the standard method were also
characterized by atomic force microscopy (AFM) in tapping mode. Figure 5.6A shows
the height image of a single hexagonal plate. The thickness of the plates was measured
and found to have a mean thickness of 90 ± 10 nm. Figure 5.6B shows the corresponding
amplitude image of the same plate. In the amplitude image, finer structures on the
surface of the microplates can be observed. When I focus on these finer features, small
regular bumps were observed on the surface of the microplate. The phase contrast image
shown in Figure 5.6C show that there were significant changes in the phase angle of the
cantilever probe along the surface, suggesting that the surface has a heterogeneous
chemical composition. The bumps are likely BSA on the surface of the Au microplate
since there were only two ingredients in this recipe, gold and BSA. Figure 5.6, D-F are
the height, amplitude, and phased contrast images, respectively, of the boxed region in
Figure 5.6C.
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To fully determine whether the bumps on the surface are BSA, I attempted to
displace the proteins from the surface. Proteins are known to be digested in a solution of
strong acid (i.e., food digestion). I soaked the Au microplates in a 50/50 solution of
HNO3 and water overnight. The gold was not expected to oxidize under this condition
because this noble metal requires both HCl and HNO3 for oxidation. Gold can form a
complex with chloride in oxidizing environments, so prior to incubation with HNO3, the
microplates were washed multiple times with water to ensure no sodium chloride was left
behind from the reaction solution. The sample was reimaged with AFM. Figure 5.7, AC, shows the height, amplitude, and phase contrast images, respectively, of the Au
microplates. The HNO3 treatment did not have any effect on the overall shape and size
of the Au microplates; however, a closer look at the surface of the microplates revealed
that the surface of the microplates had changed. The height, amplitude, and phase
contrast images of the boxed region in Figure 5.7C are shown in Figure 5.7, D-F,
respectively. The bumps on the surface of the plate no longer appear regular; instead
they seem to have aggregated into larger clumps. These results confirmed that the bumps
on the surface are indeed BSA and not gold, since the metal should not have been
affected by HNO3. The strong acid caused the protein across the surface to shrink, thus
to form larger aggregates. Additionally, no divots were observed on the surface of the
plate after HNO3 treatment, suggesting the BSA molecules are not embedded within the
Au microplates but rather reside on the surface only.

5.7 Effect of Ionic Environment
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In addition to temperature and pH, the ionic environment is important to the
structure of proteins. In a biological system, the solvent is not pure water; it contains
many ions which are involved in the regulation of protein structure and function.
Proteins have charges distributed non-uniformly across their surface. For BSA, domains
I, II, and III have a calculated net charge of -10, -8 and 0, respectively, at pH = 7. The
ions in solution stabilize these charges, and therefore the BSA structure, by direct
interactions via salt bridges, as well as indirect interactions through the electrostatic
shielding or osmotic stress.[40]

Hence, the ionic environment can induce numerous

protein conformations.
To understand the effect of ions on my synthesis, the reaction was first conducted
in the absence of any additional ions (i.e., tris, NaCl, HCl, NaOH). TBS was replaced
with 18 MΩ water in the procedure and the temperature of the reaction was varied from
37 oC to 75 oC. I observed that the removal of the ions had a stronger effect on the
reactions at lower temperatures than at higher temperatures. Figure 5.8A shows that the
product obtained at 37 oC exhibited a screw dislocation in the center of the plate. In
1949, F. C. Frank suggested that linear defects oriented normally to the growing surface
formed the core of a lattice structure, similar to a spiral staircase.[41,42] Figure 5.8B shows
a tilted SEM image of the same sample. Unlike the reaction at 37 oC, multiple screw
dislocations appeared near the edge of the plate for the reaction conducted at 55 oC,
shown in Figure 5.8D. The edge shown in the inset of Figure 5.8D was decorated with
dislocations. A possible explanation for this observation is that as the plate grew, the
strain on the surface was too great and resulted in dislocations near the edges. When the
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temperature was increased to 75 oC, screw dislocations were no longer observed. The
products synthesized were mostly hexagonal and triangular plates, and occasionally
plates adjoined together, shown in Figure 5.8D. The white arrows point out where the
edge of one plate merges with another. The inset of Figure 5.8D shows the merging
region at a higher magnification. The removal of ions from the solution has induced
conformational changes to BSA in such a way, different from the temperature and pH,
that promoted dislocations during the growth of plates. However, at higher temperatures
(75 oC), the denaturation of the protein was dominated by the temperature rather than
ionic conditions, consequently no screw dislocations were observed.
A variety of proteins are known to denature at low salt concentration.[43-46] There
are two main components of TBS: sodium chloride (NaCl) and tris (hydroxymethyl
aminomethane) (tris). NaCl is the primary constituent in the TBS solution, about five
times more than tris. NaCl is found in nearly all biological systems and is known to
affect the structure of BSA. BSA is in its native state at NaCl concentrations greater than
0.1 m. Decreasing concentrations of NaCl was previously reported to denature BSA
molecules, similar to the effect of heat-induced denaturation.[40] The other constituent is
tris, a weak base commonly used for buffers. To determine the effect these two ions have
in my system, I performed the reactions following the standard procedure, except the
TBS solution was replaced with 18 MΩ water supplemented with either NaCl or tris.
The concentration of NaCl or tris was consistent to the concentration in the standard
protocol. Figure 5.9A shows the SEM image of the products acquired when the reaction
was performed in 18 MΩ water with NaCl. Screw dislocations were not observed; Au
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microplates were synthesized once more. The hexagonal microplates had edge lengths of
3.3 ± 1.2 μm. These hexagonal plates were bigger and had a larger size distribution than
those obtained during the standard protocol. When the reaction was performed with tris
instead of NaCl, screw dislocations were again observed along with relatively small
irregular shaped particles, shown in Figure 5.9B. These products were different from
those obtained in pure water (Figure 5.8C). From these experiments, it was clear that
both NaCl and tris influenced the structure of the protein. I concluded that NaCl was
critical for the formation of microplates given that experiments carried out without NaCl
resulted in Au structures with screw dislocations. Additionally, it was possible that NaCl
may also affect the nucleation and growth of the crystal, but the exact mechanism is not
yet known. Tris alone did not seem to play a major role in synthesizing Au microplates;
however, I found that the addition of tris with NaCl yielded plates with a narrower
distribution than the reactions without tris.

Tris and NaCl may have co-solute

interactions with the protein, consequently resulting in different structures of BSA that
can affect the quality of the products. The exact structure of BSA in these conditions has
yet to be characterized.

5.7 Summary
I have examined the effect of one of the most ubiquitous proteins, BSA on the
growth of Au nanocrystals into micron-sized plates. The hydroxyl groups in BSA served
as a weak reducing agent at mild temperatures, thus providing a kinetically controlled
pathway to produce seeds with planar defects, which then grow into Au microplates.
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These hydroxyl groups were exposed by denaturing the structure of BSA through various
conditions such as temperature, pH, and the ionic environment. The cysteine residues
provided a chemical method of adhering BSA on to the Au surface to function as a
stabilizing agent. Gold microplates were obtained when the structure of BSA denatured
at 55 oC in acidic conditions containing NaCl. These Au microplates were synthesized
with biomacromolecules and can be readily translated into biosystems. For example,
they can be used as a platform for confining cellular growth or as a substrate for the
SERS detection of biomarkers. Additionally, these microplates have both nano- and
micro- characteristics.

The thickness of the Au microplates was on the scale of

nanometers which allowed them to be transparent, and the lateral dimensions were on the
scale of micrometer, which gave these plates their reflective and conductive
characteristics. Hence, Au microplates can potentially serve as transparent electrodes and
deformable mirrors. I have only begun to examine the possibilities of using biological
molecules to control the growth of nanostructures into a desired morphology. Using
biological molecules provided a simple method to control the assembly of metal atoms in
solution.

5.9 Experimental Section
TBS solutions were prepared by dissolving tris (0.030 M, Fisher) and NaCl (0.14
M) in 18 MΩ water. The pH was adjusted to 3.0, 7.4, or 10.0 using HCl or NaOH. In a
typical synthesis, BSA (0.0100 g to 0.0900 g, Aldrich, A9647) was dissolved in TBS (5.0
mL) in a 24 mL vial and the given temperature specified in the text for 30 minutes. In the
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meantime, HAuCl4 solutions (18.8 mM, Aldrich, 520198) were prepared in the
appropriate TBS solutions. After, the HAuCl4 solution (3 mL) was injected rapidly into
the vial. The entire synthesis was carried out under magnetic stirring. The reaction
solution was centrifuged at 13,200 rpm for five minutes. The Au structures were then
suspended in water by sonication while the protein remained as a pellet. The supernatant
containing Au plates was washed with water three times to further remove BSA. A drop
of the aqueous suspension of the Au product was placed on a piece of silicon water (for
SEM and AFM) or carbon-coated copper grid (Ted Pella, Redding, CA, for TEM and
ED) and dried under ambient conditions for characterization.

SEM images were

collected using a FEI field-emission scanning microscope (Sirion XL) operated at an
accelerating voltage of 10 kV. TEM images and ED patterns were captured using a
Phillips 420 transmission electron microscope operated at 100 kV. Height, amplitude,
and phase contrast images were collected simultaneously in tapping mode using a
Nanoscope V Multimode SPM (Veeco Instruments Inc.).
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Table 5.1 pH-Dependent Conformations for BSA (reproduced from ref. [32])

State

E

F
N
B
A
Fast
ÅÆ Normal ÅÆ Basic ÅÆ Aged
Description Expanded ÅÆ
migration
pH of
2.7
4.3
8
10
transition
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Figure 5.1 (A) Illustration of a portion of BSA undergoing structural changes when

exposed to heat and HAuCl4. The protein unfolds and the disulfide bonds break thereby
exposing the reductive hydroxyl groups in threonine and serine. (B) SEM and (C, D)
TEM images of hexagonal and triangular plates synthesized using the standard procedure,
with the addition of 3 mL of 18.8 mM HAuCl4 into a 5 mL TBS solution (pH = 7.4)
containing 0.050 g BSA at 55 oC for 2 hours. The insets in (C) and (D) show the
corresponding ED pattern taken by directing the electron beam perpendicular to the flat
faces of each plate. The spots squared, triangled, and circled can be indexed to the
{220}, {422}, and forbidden 1/3{422} reflections, respectively.
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Figure 5.2 Influence of temperature on size and morphology. (A) TEM and (B-D) SEM

images of the products synthesized using the standard procedure except at a temperature
of 4, 37, 65, and 75 oC, respectively. The scale bar in the inset is 200 nm.
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Figure 5.3 Influence of BSA structure on the size and morphology. A SEM image of

the product obtained using the standard protocol, except that the BSA solution was heated
beforehand for 30 minutes at 75 oC and then reduced to 55 oC.
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Figure 5.4 Influence of pH value on size and morphology. (A) SEM and (B) TEM

images of the products synthesized using the standard procedure, except at starting pH
values of 3.0 and 10.0, respectively.
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Figure 5.5 Influence of BSA concentration on size and morphology. SEM images of

products synthesized using the standard procedure, except with different amounts of
BSA: (A) 0.03, (B) 0.04, (C) 0.07, and (D) 0.09 g.
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Figure 5.6 AFM characterization of the surface of a Au microplate. AFM height (A),

amplitude (B), and phase contrast (C) images of a Au microplate synthesized using the
standard procedure. (C-F) Height, amplitude, and phase contrast images, respectively, of
the boxed region in (C).
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Figure 5.7 AFM height (A), amplitude (B), and phase contrast (C) images of Au

microplates synthesized using the standard procedure after HNO3 treatment in an attempt
to remove BSA from the surface. (C-F) Height, amplitude, and phase contrast images,
respectively, of the boxed region in (C). The aggregation of the bumps after treatment
with HNO3 indicated that it was BSA residing on the surface of the Au microplate.
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Figure 5.8

Influence of ions on size and morphology.

SEM images of products

synthesized using the standard procedure except replacing the TBS solution with 18 MΩ
water at (A, B) 37, (C) 55, and (D) 75 oC. (B) A tilted SEM image of the same sample in
(A) showing the screw dislocation. (D) The arrows point to the junction between two
adjoining plates. The scale bars in the insets are 2 μm.
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Figure 5.9 Influence of NaCl and tris on size and morphology. SEM image of the

products synthesized using the standard procedure, except that the TBS was substituted
with 18 MΩ water supplemented with (A) NaCl and (B) tris.
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Chapter 6

Conclusion

For my dissertation, I developed some novel Au nanostructures and tailored their
optical properties for biomedical applications.

For Au nanocages, their size, wall

thickness, and porosity determined the LSPR peak position as well as their scattering and
absorption cross-sections.

By tuning their LSPR peak to the near-infrared region and

maximizing their absorption to scattering ratio, Au nanocages were used for imaging and
photoablation of cancerous cells.
Gold nanocages with hollow interiors and porous walls were synthesized through
the galvanic replacement reaction of Ag nanocubes and AuCl4-. By controlling the
amount of AuCl4- added to the reaction, the LSPR peak could be tuned from 400 nm to
the near-infrared region. DDA calculations show that the Au nanocages have strong
absorption cross-sections, about five orders of magnitude larger than organic dyes.
As an extension to the replacement reaction, I compared the galvanic replacement
reactions between Ag nanocubes and two Au precursors with different oxidation
numbers: AuCl2- and AuCl4-. Both reactions resulted in hollow nanostructures, but the
Au nanostructures produced were thicker for the reaction with AuCl2- than AuCl4-. This
effect was attributed to the stoichiometric change between the number of Ag atom(s)
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consumed per Au atom formed (1:1 versus 3:1). The thicker edges and thus more robust
structures were able to survive the dealloying process to form Au nanoframes.
The galvanic replacement reaction of Ag nanocubes and AuCl2- formed
nanoframes, a novel shape with all faces open. I studied the relationship between LSPR
properties and the variations in edge length, ridge thickness, and corner sharpness using
single-nanoparticle spectroscopy and DDA calculations. These results confirmed that the
LSPR peak red-shifted with increasing ratio between the outer edge length and the ridge
thickness. Additionally, the scattering intensity of the peak increased as this ratio value
increased. Lastly, I demonstrated that Au nanoframes are promising substrates for SERS.
After optimizing the synthesis and LSPR properties, I applied the Au nanocages
to the imaging of cancer cells. I functionalized the surface of the Au nanocages with
anti-EGFR antibodies to target the overexpressed EGFR on the surface of
U87MGwtEGFR cancer cells. I evaluated the uptake of anti-EGFR Au nanocages by the
cells using two-photon confocal microscopy under different conditions (i.e. temperature,
time of incubation, number of antibodies on the nanocage, and size of nanocage). The
results further enhance the understanding of how Au nanostructures interact with cells as
well as provide insight on the optimal conditions for cellular uptake of the Au nanocages.
In general, smaller nanocages ~35 nm, longer incubation time 24 h, and larger number of
antibodies per nanocage resulted in an increased uptake of anti-EGFR nanocages. The
qualitative PL results agreed well with the quantitative analysis of Au by ICP-MS. The
two-photon PL from Au nanocages can be used to quickly screen for cancer cells, as well
as evaluate their distribution in tissue for ex vivo and in vivo studies.
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For the photothermal treatment of cancer cells, I quantified the photothermal
effect of anti-EGFR Au nanocages on SK-BR-3 cells using flow cytometry. First, I
determined that there were approximately 400 nanocages per cell using ICP-MS. Then I
investigated the relationship between laser parameters and cellular damage. The cellular
death increased linearly after a power threshold of 1.6 W/cm2. Additionally, the cellular
death increased as the time of exposure increased to 5 minutes, after the cellular death
became steady. These result provide insights into how the photothermal response of Au
nanocages can be optimized and controlled for the future in vivo treatment of cancer.
Lastly, I synthesized Au microplates using the hydroxyl groups in BSA as the
reductant.

Temperature, pH, and salt concentration all played important roles in

unfolding the BSA molecule to expose the hydroxyl group. The optimal conditions for
producing Au microplates were the following: 1) 55 oC when the BSA was irreversibly
denatured, 2) acidic pH when the BSA was elongated, 3) in the TBS. BSA molecules
were attached to the surface of the Au microplates likely through Au-thiolate bonds.
These as-synthesized microplates can serve as substrates as confining cellular growth.
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